,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,17,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Confirmatory,,
9,19,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
10,21,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
11,23,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
12,25,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
13,27,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
14,29,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
15,31,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
16,33,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
17,35,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
18,37,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
19,39,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
20,41,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
21,43,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
22,45,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
23,47,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
24,49,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
25,51,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
26,53,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
27,55,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
28,57,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
29,59,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
30,61,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
31,63,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
32,65,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
33,67,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
34,69,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
35,71,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
36,73,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
37,75,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
38,77,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
39,79,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
40,81,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
41,99,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
42,101,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
43,103,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
44,105,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
45,107,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
46,109,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
47,113,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
48,115,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
49,119,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
50,121,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
51,123,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
52,125,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
53,129,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
54,131,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
55,133,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
56,135,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF-631 Renal cell line,Confirmatory,,
57,137,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
58,139,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
59,141,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
60,143,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
61,145,1,1,,106262,689043,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
62,155,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
63,157,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
64,161,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
65,165,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
66,167,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
67,175,1,1,,106262,689043,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
68,179,1,1,,106262,689043,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
69,248,1,1,,106262,689043,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
70,330,1,1,,106262,689043,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
71,357,2,1,,855772,689043,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
72,361,1,2,,855772,689043,Inactive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
73,364,1,3,,855772,689043,Inactive,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
74,368,2,3,,855772,689043,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
75,371,1,1,,855772,689043,Inactive,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
76,373,1,4,,855772,689043,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
77,374,2,3,,855772,689043,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
78,375,2,3,,855772,689043,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
79,411,2,1,,855772,689043,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
80,422,1,5,,855772,689043,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
81,422,1,5,,17404771,689043,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
82,425,3,2,,855772,689043,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
83,429,1,5,,855772,689043,Active,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
84,429,1,5,,855772,689043,Active,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
85,429,1,5,,17404771,689043,Active,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
86,429,1,5,,17404771,689043,Active,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
87,430,2,4,,855772,689043,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
88,431,2,4,,855772,689043,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
89,432,2,4,,855772,689043,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
90,436,2,1,,855772,689043,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
91,436,2,1,,17404771,689043,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
92,438,1,4,,855772,689043,Inactive,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
93,440,3,3,,855772,689043,Inactive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
94,441,3,3,,855772,689043,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
95,444,1,1,,855772,689043,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
96,446,1,1,,855772,689043,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
97,449,1,5,,855772,689043,Inactive,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
98,450,1,2,,855772,689043,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
99,454,1,7,,855772,689043,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
100,455,1,7,,855772,689043,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
101,456,1,7,,855772,689043,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
102,457,1,7,,855772,689043,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
103,460,2,2,,855772,689043,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
104,483,1,6,,855772,689043,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
105,485,1,8,,855772,689043,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
106,487,1,2,,855772,689043,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
107,488,2,1,,855772,689043,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
108,501,2,2,,855772,689043,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
109,518,2,6,,855772,689043,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
110,521,2,5,,855772,689043,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
111,522,1,2,,855772,689043,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
112,524,1,3,,855772,689043,Inactive,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
113,525,1,3,,855772,689043,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
114,527,3,1,,855772,689043,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
115,528,1,4,,855772,689043,Inactive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
116,529,1,4,,855772,689043,Inactive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
117,538,2,2,,855772,689043,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
118,539,1,2,,855772,689043,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
119,547,1,4,,17404771,689043,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
120,552,1,3,,855772,689043,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
121,555,1,2,,855772,689043,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
122,556,1,3,,855772,689043,Inactive,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
123,559,2,2,,855772,689043,Active,147728.0,,,,RNA polymerase,Screening,,
124,560,1,2,,855772,689043,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
125,561,1,3,,855772,689043,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
126,565,1,4,,855772,689043,Active,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
127,567,1,4,,855772,689043,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
128,568,1,7,,855772,689043,Inactive,5729877.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
129,568,1,7,,855772,689043,Inactive,24234686.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
130,570,1,4,,855772,689043,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
131,571,1,4,,855772,689043,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
132,572,1,5,,855772,689043,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
133,573,1,4,,855772,689043,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
134,574,1,3,,855772,689043,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
135,575,1,4,,855772,689043,Inactive,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
136,576,1,2,,855772,689043,Inactive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
137,577,1,1,,855772,689043,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
138,578,2,2,,8034051,689043,Inactive,61354647.0,,,,Literature data for small-molecule inhibitors of EGF-R_Tyrosine _Kinase_Homo_sapiens,Other,2552117.0,
139,580,1,5,,855772,689043,Inactive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
140,581,2,2,,855772,689043,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
141,583,2,6,,855772,689043,Inactive,123271505.0,,,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
142,587,1,5,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
143,588,1,4,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
144,589,1,3,,855772,689043,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
145,590,1,3,,855772,689043,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
146,591,1,4,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
147,592,1,6,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
148,593,1,4,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
149,594,1,4,,855772,689043,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
150,597,1,3,,855772,689043,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
151,598,1,4,,855772,689043,Inactive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen,Screening,,
152,601,1,4,,855772,689043,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
153,602,1,4,,855772,689043,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance,Screening,,
154,604,1,3,,855772,689043,Inactive,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
155,606,1,3,,855772,689043,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
156,606,1,3,,855772,689043,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
157,608,1,6,,11537800,689043,Inactive,17149836.0,2280.0,,,NMR Based Screening Assay for FKBP12,Other,,
158,609,1,2,,855772,689043,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
159,614,1,6,,855772,689043,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
160,615,1,6,,855772,689043,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
161,618,2,6,,855772,689043,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
162,620,2,5,,855772,689043,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
163,622,1,2,,855772,689043,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
164,623,1,3,,855772,689043,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
165,624,1,2,,855772,689043,Inactive,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
166,625,1,2,,855772,689043,Inactive,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
167,626,1,3,,855772,689043,Inactive,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
168,628,2,4,,855772,689043,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
169,629,1,3,,855772,689043,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors,Screening,,
170,630,1,1,,855772,689043,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
171,631,1,4,,855772,689043,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
172,631,1,4,,855772,689043,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
173,633,1,3,,855772,689043,Active,10835013.0,2100.0,,,HTS for Estrogen Receptor-beta Coactivator Binding inhibitors,Screening,,
174,636,1,4,,855772,689043,Inactive,,,,,Modulators of Post-Golgi Transport - 384-well pilot screen,Screening,,
175,637,1,4,,855772,689043,Inactive,,,,,Modulators of Post-Golgi Transport - 1536-well pilot screen,Screening,,
176,639,1,2,,855772,689043,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators,Screening,,
177,641,1,4,,855772,689043,Inactive,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
178,645,1,4,,855772,689043,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
179,648,1,3,,855772,689043,Inactive,,,,,Human Endothelial Cell Proliferation Assay in 384-well format,Screening,,
180,651,1,3,,855772,689043,Active,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605 Confirmation Assay,Screening,,
181,652,1,3,,855772,689043,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN MH077605 Probe Assessment: Dose response Assay,Confirmatory,,
182,680,1,10,,855772,689043,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
183,684,1,12,,855772,689043,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
184,686,1,1,,855772,689043,Inactive,,,,,Zebrafish Lipid Metabolism Assay---Primary Screen,Screening,,
185,687,1,17,,855772,689043,Inactive,180352.0,,,,Factor XIa Single Well HTS,Screening,,
186,694,1,1,,17404771,689043,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
187,701,1,17,,855772,689043,Inactive,317373446.0,2161.0,,,Factor XIIa Single Well HTS,Screening,,
188,708,1,4,,855772,689043,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
189,709,1,2,,855772,689043,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
190,712,1,4,,855772,689043,Inactive,4261762.0,3326.0,50.0,IC50,Tumor Hsp90 Inhibitors Dose Response Confirmation,Confirmatory,,
191,712,1,4,,855772,689043,Inactive,154146191.0,3320.0,50.0,IC50,Tumor Hsp90 Inhibitors Dose Response Confirmation,Confirmatory,,
192,719,1,3,,855772,689043,Inactive,,,,,Human Lung Fibroblast Proliferation Assay,Screening,,
193,731,1,5,,855772,689043,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
194,731,1,5,,855772,689043,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
195,732,1,2,,17404771,689043,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
196,746,1,1,,855772,689043,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
197,750,1,3,,855772,689043,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
198,751,1,3,,855772,689043,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
199,757,1,4,,855772,689043,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
200,758,1,4,,855772,689043,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
201,759,1,4,,855772,689043,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
202,760,1,4,,855772,689043,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
203,761,1,4,,855772,689043,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
204,764,1,4,,855772,689043,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
205,770,1,1,,855772,689043,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
206,771,1,2,,855772,689043,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
207,772,1,2,,855772,689043,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
208,774,1,2,,855772,689043,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
209,775,1,3,,855772,689043,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
210,781,1,1,,855772,689043,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
211,782,1,2,,855772,689043,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
212,782,1,2,,855772,689043,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
213,793,1,2,,855772,689043,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
214,795,1,1,,855772,689043,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
215,797,1,1,,855772,689043,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
216,798,2,12,,855772,689043,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
217,799,1,5,,855772,689043,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
218,800,2,11,,855772,689043,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
219,803,1,4,,855772,689043,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
220,804,1,3,,855772,689043,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
221,813,1,4,,855772,689043,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
222,817,1,1,,855772,689043,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
223,818,1,2,,855772,689043,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
224,826,2,1,,855772,689043,Active,147728.0,,23.7759,IC50 mean,RNA polymerase dose-response confirmation,Confirmatory,,
225,827,1,2,,855772,689043,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
226,828,1,5,,855772,689043,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
227,834,1,3,,855772,689043,Inactive,,,,,C. albicans biofilm killing,Screening,,
228,841,1,1,,855772,689043,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
229,847,1,2,,855772,689043,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
230,861,1,1,,855772,689043,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
231,862,1,2,,855772,689043,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
232,868,1,3,,855772,689043,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
233,871,1,2,,855772,689043,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
234,873,1,13,,855772,689043,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
235,875,1,2,,855772,689043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
236,878,1,2,,855772,689043,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
237,879,1,2,,855772,689043,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
238,879,1,2,,855772,689043,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
239,880,2,1,,855772,689043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
240,880,2,1,,855772,689043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
241,880,2,1,,26746990,689043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
242,880,2,1,,26746990,689043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
243,880,2,1,,50104061,689043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
244,880,2,1,,50104061,689043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
245,880,2,1,,50104062,689043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
246,880,2,1,,50104062,689043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
247,880,2,1,,50104063,689043,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
248,880,2,1,,50104063,689043,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
249,881,2,2,,855772,689043,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
250,884,1,2,,855772,689043,Inconclusive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
251,885,1,2,,855772,689043,Inactive,13435386.0,1576.0,25.1189,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
252,886,1,2,,855772,689043,Active,122921310.0,,1.9953,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
253,886,1,2,,855772,689043,Active,122921311.0,,1.9953,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
254,887,1,2,,855772,689043,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
255,889,1,3,,855772,689043,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
256,892,1,2,,855772,689043,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
257,893,1,2,,855772,689043,Inconclusive,122921310.0,,10.0,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
258,893,1,2,,855772,689043,Inconclusive,122921311.0,,10.0,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
259,894,2,1,,855772,689043,Inconclusive,31542939.0,3248.0,39.8107,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
260,894,2,1,,26746990,689043,Inconclusive,31542939.0,3248.0,39.8107,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
261,894,2,1,,50104061,689043,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
262,894,2,1,,50104062,689043,Inconclusive,31542939.0,3248.0,39.8107,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
263,894,2,1,,50104063,689043,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
264,895,1,2,,855772,689043,Inconclusive,21620132.0,4790.0,0.1413,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
265,898,1,1,,855772,689043,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
266,900,1,3,,855772,689043,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
267,901,1,2,,855772,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
268,902,1,2,,855772,689043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
269,910,1,2,,855772,689043,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
270,914,1,3,,855772,689043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
271,915,1,3,,855772,689043,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
272,917,1,3,,855772,689043,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
273,918,1,3,,855772,689043,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
274,920,1,2,,855772,689043,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
275,923,1,2,,855772,689043,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
276,924,1,2,,855772,689043,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
277,927,1,3,,855772,689043,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
278,928,1,2,,855772,689043,Inconclusive,21620132.0,4790.0,0.1413,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
279,930,1,2,,855772,689043,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
280,932,1,4,,855772,689043,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
281,940,1,2,,855772,689043,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
282,940,1,2,,17404771,689043,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
283,940,1,2,,26612575,689043,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
284,943,1,2,,855772,689043,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
285,944,1,2,,855772,689043,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
286,945,1,4,,855772,689043,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
287,950,1,1,,855772,689043,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
288,951,1,1,,855772,689043,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
289,952,1,1,,855772,689043,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
290,954,1,2,,855772,689043,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
291,957,1,2,,855772,689043,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
292,958,1,2,,855772,689043,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
293,959,1,4,,855772,689043,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
294,992,1,3,,855772,689043,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
295,995,1,2,,855772,689043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
296,997,1,2,,855772,689043,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
297,998,1,2,,855772,689043,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
298,1001,2,2,,855772,689043,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
299,1006,1,6,,855772,689043,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
300,1007,1,1,,855772,689043,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
301,1008,1,2,,855772,689043,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
302,1009,1,2,,855772,689043,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
303,1012,1,4,,855772,689043,Active,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
304,1016,1,4,,855772,689043,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
305,1018,2,5,,855772,689043,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
306,1019,1,4,,855772,689043,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
307,1020,1,5,,855772,689043,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
308,1021,1,1,,855772,689043,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
309,1022,1,1,,855772,689043,Active,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
310,1027,1,3,,855772,689043,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
311,1030,2,1,,855772,689043,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
312,1030,2,1,,26746990,689043,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
313,1030,2,1,,50104061,689043,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
314,1030,2,1,,50104062,689043,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
315,1030,2,1,,50104063,689043,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
316,1032,1,2,,855772,689043,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
317,1032,1,2,,855772,689043,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
318,1033,2,2,,11537800,689043,Inactive,216546.0,,,,NMR Based Screening Assay for the substrate binding domain of the chaperone DnaK,Screening,,
319,1040,1,2,,855772,689043,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
320,1048,1,1,,855772,689043,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
321,1048,1,1,,855772,689043,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
322,1049,1,1,,855772,689043,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
323,1049,1,1,,855772,689043,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
324,1051,1,1,,855772,689043,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
325,1051,1,1,,855772,689043,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
326,1063,1,1,,855772,689043,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
327,1066,1,2,,855772,689043,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
328,1085,1,1,,855772,689043,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
329,1135,1,3,,855772,689043,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
330,1136,1,3,,855772,689043,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
331,1189,1,5,,48413363,689043,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
332,1194,1,3,,48413363,689043,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
333,1199,1,3,,48413363,689043,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
334,1203,1,3,,855772,689043,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
335,1205,1,4,,48413363,689043,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
336,1208,1,3,,48413363,689043,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
337,1209,2,2,,855772,689043,Active,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
338,1214,1,4,,855772,689043,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
339,1216,1,5,,855772,689043,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
340,1217,1,4,,855772,689043,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
341,1220,2,2,,855772,689043,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
342,1222,1,6,,855772,689043,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
343,1229,1,3,,855772,689043,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
344,1235,1,2,,855772,689043,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
345,1236,1,1,,855772,689043,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
346,1239,1,3,,855772,689043,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
347,1239,1,3,,855772,689043,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
348,1242,1,1,,855772,689043,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
349,1251,1,1,,855772,689043,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
350,1273,1,1,,855772,689043,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
351,1274,1,2,,855772,689043,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
352,1276,1,1,,855772,689043,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
353,1285,1,1,,855772,689043,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
354,1296,1,1,,855772,689043,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
355,1304,1,2,,855772,689043,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
356,1321,1,2,,855772,689043,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
357,1325,1,2,,855772,689043,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
358,1326,1,4,,855772,689043,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
359,1332,1,1,,49699041,689043,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
360,1359,1,4,,855772,689043,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
361,1362,1,2,,855772,689043,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
362,1376,1,2,,855772,689043,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
363,1377,1,1,,855772,689043,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
364,1379,1,2,,855772,689043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
365,1379,1,2,,26746990,689043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
366,1379,1,2,,50104061,689043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
367,1379,1,2,,50104062,689043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
368,1379,1,2,,50104063,689043,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
369,1381,1,1,,855772,689043,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
370,1385,2,2,,855772,689043,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
371,1415,1,2,,855772,689043,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
372,1415,1,2,,855772,689043,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
373,1416,1,2,,855772,689043,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
374,1422,1,1,,855772,689043,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
375,1422,1,1,,17404771,689043,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
376,1422,1,1,,26612575,689043,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
377,1423,1,2,,855772,689043,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
378,1423,1,2,,855772,689043,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
379,1424,1,1,,855772,689043,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
380,1430,1,1,,855772,689043,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
381,1434,2,3,,855772,689043,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
382,1434,2,3,,855772,689043,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
383,1438,2,3,,855772,689043,Inactive,13124881.0,865.0,,IC50,Identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a time resolved fluorescence resonance energy transfer (TR-FRET) assay.,Confirmatory,,
384,1438,2,3,,855772,689043,Inactive,19923198.0,861.0,,IC50,Identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a time resolved fluorescence resonance energy transfer (TR-FRET) assay.,Confirmatory,,
385,1439,1,1,,855772,689043,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
386,1439,1,1,,855772,689043,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
387,1440,1,1,,855772,689043,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
388,1440,1,1,,855772,689043,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
389,1441,1,1,,855772,689043,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
390,1441,1,1,,855772,689043,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
391,1443,1,3,,855772,689043,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
392,1445,1,1,,855772,689043,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
393,1446,1,3,,855772,689043,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
394,1448,1,3,,855772,689043,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
395,1452,1,1,,855772,689043,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
396,1454,1,1,,855772,689043,Inconclusive,66932916.0,5594.0,8.9125,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
397,1454,1,1,,26746990,689043,Inconclusive,66932916.0,5594.0,14.1254,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
398,1454,1,1,,50104061,689043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
399,1454,1,1,,50104062,689043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
400,1454,1,1,,50104063,689043,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
401,1456,1,1,,855772,689043,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
402,1457,1,1,,855772,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
403,1457,1,1,,26746990,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
404,1457,1,1,,50104061,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
405,1457,1,1,,50104062,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
406,1457,1,1,,50104063,689043,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
407,1458,1,1,,855772,689043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
408,1458,1,1,,26746990,689043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
409,1458,1,1,,50104061,689043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
410,1458,1,1,,50104063,689043,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
411,1459,1,1,,50104061,689043,Inactive,27436948.0,4000.0,,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
412,1460,1,3,,855772,689043,Inconclusive,92096784.0,4137.0,44.6684,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
413,1460,1,3,,26746990,689043,Inconclusive,92096784.0,4137.0,10.0,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
414,1460,1,3,,50104061,689043,Inconclusive,92096784.0,4137.0,15.8489,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
415,1460,1,3,,50104062,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
416,1460,1,3,,50104063,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
417,1461,1,2,,855772,689043,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
418,1461,1,2,,50104061,689043,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
419,1463,1,1,,855772,689043,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
420,1463,1,1,,26746990,689043,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
421,1463,1,1,,50104061,689043,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
422,1463,1,1,,50104062,689043,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
423,1463,1,1,,50104063,689043,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
424,1465,1,1,,855772,689043,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
425,1466,1,2,,855772,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
426,1467,1,3,,26746990,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
427,1467,1,3,,50104061,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
428,1467,1,3,,50104062,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
429,1467,1,3,,50104063,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
430,1468,1,1,,855772,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
431,1468,1,1,,26746990,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
432,1468,1,1,,50104061,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
433,1468,1,1,,50104062,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
434,1468,1,1,,50104063,689043,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
435,1469,1,1,,855772,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
436,1469,1,1,,26746990,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
437,1469,1,1,,26751505,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
438,1469,1,1,,50104061,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
439,1469,1,1,,50104062,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
440,1469,1,1,,50104063,689043,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
441,1471,2,1,,50104062,689043,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
442,1471,2,1,,50104063,689043,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
443,1476,2,1,,855772,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
444,1476,2,1,,26746990,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
445,1476,2,1,,50104061,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
446,1476,2,1,,50104062,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
447,1476,2,1,,50104063,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
448,1477,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
449,1477,1,1,,26751505,689043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
450,1477,1,1,,50104061,689043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
451,1477,1,1,,50104062,689043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
452,1477,1,1,,50104063,689043,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
453,1478,2,1,,855772,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
454,1478,2,1,,26746990,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
455,1478,2,1,,50104061,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
456,1478,2,1,,50104062,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
457,1478,2,1,,50104063,689043,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
458,1479,1,2,,855772,689043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
459,1479,1,2,,26746990,689043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
460,1479,1,2,,26751505,689043,Inconclusive,189491771.0,7068.0,12.5893,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
461,1479,1,2,,50104061,689043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
462,1479,1,2,,50104062,689043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
463,1479,1,2,,50104063,689043,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
464,1481,1,2,,855772,689043,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
465,1486,1,3,,855772,689043,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
466,1487,1,1,,855772,689043,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
467,1487,1,1,,26746990,689043,Inconclusive,27436948.0,4000.0,2.8184,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
468,1487,1,1,,50104061,689043,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
469,1490,2,1,,855772,689043,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
470,1490,2,1,,26746990,689043,Active,10954339.0,,39.8107,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
471,1490,2,1,,26751505,689043,Active,10954339.0,,7.0795,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
472,1490,2,1,,50104062,689043,Active,10954339.0,,50.1187,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
473,1490,2,1,,50104063,689043,Active,10954339.0,,56.2341,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
474,1496,1,4,,855772,689043,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
475,1496,1,4,,855772,689043,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
476,1509,1,2,,855772,689043,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
477,1510,1,3,,855772,689043,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
478,1511,1,3,,855772,689043,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
479,1515,1,2,,855772,689043,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
480,1519,1,3,,26746990,689043,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
481,1519,1,3,,50104061,689043,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
482,1519,1,3,,50104062,689043,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
483,1527,1,3,,855772,689043,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
484,1529,1,1,,855772,689043,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
485,1530,1,1,,855772,689043,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
486,1531,1,1,,855772,689043,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
487,1532,1,1,,855772,689043,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
488,1549,1,2,,11537800,689043,Inactive,89033149.0,,,,NMR Based Screening Assay for Novel Chemotypes against influenza A virus,Other,,
489,1552,1,3,,11537800,689043,Inactive,4507793.0,7334.0,,,NMR assay targeting the ubiquitin-proteasome system to modulate protein folding and degradation,Other,,
490,1554,1,1,,855772,689043,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
491,1556,1,4,,855772,689043,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
492,1565,2,2,,855772,689043,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
493,1566,2,3,,855772,689043,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
494,1578,3,2,,855772,689043,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
495,1619,1,2,,855772,689043,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
496,1621,1,2,,855772,689043,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
497,1626,1,2,,855772,689043,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
498,1631,3,1,,855772,689043,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
499,1634,3,1,,855772,689043,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
500,1637,1,2,,11537800,689043,Inactive,,,,,NMR Based Screening Assay for Influenza A RNA Promoter,Other,,
501,1648,1,2,,11537800,689043,Inactive,159164579.0,,,,NMR Based Screening Assay For Novel Chemical Probes Targeting The FRB Domain of mTOR,Other,,
502,1654,2,2,,855772,689043,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
503,1656,2,2,,855772,689043,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
504,1662,1,2,,855772,689043,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
505,1663,1,2,,855772,689043,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
506,1665,2,2,,855772,689043,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
507,1672,1,3,,855772,689043,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
508,1688,1,1,,855772,689043,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
509,1700,1,2,,855772,689043,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
510,1705,1,2,,50104061,689043,Inactive,6980812.0,,,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
511,1706,1,2,,855772,689043,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
512,1707,1,3,,50104061,689043,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
513,1708,1,3,,50104061,689043,Inactive,405898.0,,25.1189,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
514,1721,1,2,,855772,689043,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
515,1722,1,2,,855772,689043,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
516,1766,1,1,,855772,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
517,1766,1,1,,855772,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
518,1766,1,1,,26746990,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
519,1766,1,1,,26746990,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
520,1766,1,1,,26751505,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
521,1766,1,1,,26751505,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
522,1766,1,1,,50104061,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
523,1766,1,1,,50104061,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
524,1766,1,1,,50104062,689043,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
525,1766,1,1,,50104062,689043,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
526,1766,1,1,,50104063,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
527,1766,1,1,,50104063,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
528,1768,1,1,,855772,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
529,1768,1,1,,855772,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
530,1768,1,1,,26746990,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
531,1768,1,1,,26746990,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
532,1768,1,1,,26751505,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
533,1768,1,1,,26751505,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
534,1768,1,1,,50104061,689043,Inactive,18860839.0,4221.0,1.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
535,1768,1,1,,50104061,689043,Inactive,56550039.0,4297.0,1.0,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
536,1768,1,1,,50104062,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
537,1768,1,1,,50104062,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
538,1768,1,1,,50104063,689043,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
539,1768,1,1,,50104063,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
540,1775,1,2,,855772,689043,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
541,1776,1,2,,855772,689043,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
542,1777,3,2,,855772,689043,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
543,1778,3,3,,855772,689043,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
544,1779,2,2,,855772,689043,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
545,1789,1,2,,855772,689043,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
546,1800,1,2,,855772,689043,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
547,1813,1,2,,855772,689043,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
548,1814,1,2,,855772,689043,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
549,1815,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
550,1816,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
551,1817,2,2,,855772,689043,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
552,1822,1,3,,855772,689043,Active,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
553,1825,1,1,,855772,689043,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
554,1828,2,1,,50104061,689043,Inactive,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
555,1832,2,1,,855772,689043,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
556,1845,1,2,,855772,689043,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
557,1850,2,1,,855772,689043,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
558,1861,2,1,,855772,689043,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
559,1862,1,4,,855772,689043,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_RPL19A,Screening,,
560,1863,2,1,,855772,689043,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
561,1865,1,1,,855772,689043,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
562,1865,1,1,,26746990,689043,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
563,1865,1,1,,50104061,689043,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
564,1865,1,1,,50104062,689043,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
565,1865,1,1,,50104063,689043,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
566,1867,1,4,,855772,689043,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_MEP2,Screening,,
567,1868,1,4,,855772,689043,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
568,1870,1,4,,855772,689043,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_CIT2,Screening,,
569,1873,1,4,,855772,689043,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_LAP4,Screening,,
570,1875,2,1,,855772,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
571,1876,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
572,1877,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
573,1882,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
574,1883,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
575,1885,2,1,,855772,689043,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
576,1886,1,1,,50104061,689043,Inactive,,,,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
577,1887,1,4,,855772,689043,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_AGP1,Screening,,
578,1899,1,3,,855772,689043,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
579,1903,2,3,,855772,689043,Active,297591903.0,29031019.0,7.3,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
580,1906,1,3,,855772,689043,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
581,1910,1,2,,855772,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
582,1947,1,2,,855772,689043,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
583,1948,1,1,,26746990,689043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
584,1948,1,1,,50104061,689043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
585,1948,1,1,,50104062,689043,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
586,1950,1,3,,855772,689043,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
587,1956,1,1,,855772,689043,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
588,1961,2,2,,855772,689043,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
589,1962,1,2,,855772,689043,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
590,1967,1,1,,85231345,689043,Inconclusive,4505907.0,5376.0,84.9214,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
591,1974,1,2,,855772,689043,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
592,1979,1,1,,855772,689043,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
593,1984,1,3,,855772,689043,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
594,1986,1,2,,855772,689043,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
595,1987,1,2,,855772,689043,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
596,2006,3,2,,855772,689043,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
597,2006,3,2,,855772,689043,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
598,2006,3,2,,855772,689043,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
599,2012,3,2,,855772,689043,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
600,2013,2,2,,855772,689043,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
601,2014,3,2,,855772,689043,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
602,2016,1,3,,855772,689043,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
603,2023,1,3,,855772,689043,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
604,2025,1,3,,855772,689043,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
605,2029,1,3,,855772,689043,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
606,2052,2,1,,855772,689043,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
607,2057,1,2,,855772,689043,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
608,2058,3,2,,855772,689043,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
609,2066,1,4,,855772,689043,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
610,2071,2,2,,855772,689043,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
611,2073,2,3,,855772,689043,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
612,2073,2,3,,855772,689043,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
613,2094,1,2,,855772,689043,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
614,2094,1,2,,855772,689043,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
615,2094,1,2,,855772,689043,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
616,2097,1,2,,855772,689043,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
617,2098,1,1,,855772,689043,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
618,2099,1,1,,855772,689043,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
619,2100,1,1,,855772,689043,Active,119393891.0,2548.0,7.9433,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
620,2101,1,1,,855772,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
621,2101,1,1,,26746990,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
622,2101,1,1,,26751505,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
623,2101,1,1,,50104061,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
624,2101,1,1,,50104062,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
625,2101,1,1,,50104063,689043,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
626,2102,1,2,,855772,689043,Inactive,297591903.0,29031019.0,,EC50,Identification of SV40 T antigen inhibitors: Cytotoxicity screen of selected hits,Confirmatory,,
627,2107,1,1,,855772,689043,Inconclusive,757912.0,2717.0,50.1187,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
628,2107,1,1,,26746990,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
629,2107,1,1,,26751505,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
630,2107,1,1,,50104061,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
631,2107,1,1,,50104062,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
632,2107,1,1,,50104063,689043,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
633,2112,1,1,,855772,689043,Inconclusive,119393891.0,2548.0,39.8107,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
634,2112,1,1,,26746990,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
635,2112,1,1,,26751505,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
636,2112,1,1,,50104061,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
637,2112,1,1,,50104062,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
638,2112,1,1,,50104063,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
639,2129,1,2,,855772,689043,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
640,2130,1,3,,855772,689043,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
641,2147,1,1,,855772,689043,Active,221046486.0,,0.5623,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
642,2147,1,1,,26746990,689043,Inconclusive,221046486.0,,14.1254,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
643,2147,1,1,,50104061,689043,Active,221046486.0,,15.8489,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
644,2147,1,1,,50104062,689043,Inconclusive,221046486.0,,25.1189,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
645,2147,1,1,,50104063,689043,Inconclusive,221046486.0,,22.3872,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
646,2156,2,2,,855772,689043,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
647,2174,1,3,,855772,689043,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
648,2177,1,3,,855772,689043,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
649,2205,1,1,,855772,689043,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
650,2216,1,3,,855772,689043,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
651,2221,1,2,,855772,689043,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
652,2227,1,2,,855772,689043,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
653,2234,1,2,,855772,689043,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
654,2235,1,2,,855772,689043,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
655,2237,1,2,,855772,689043,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
656,2239,1,2,,855772,689043,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
657,2240,1,1,,85787363,689043,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
658,2241,1,1,,85787363,689043,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
659,2242,1,1,,855772,689043,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
660,2247,1,2,,855772,689043,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
661,2275,1,1,,85787363,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
662,2280,2,3,,855772,689043,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
663,2288,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
664,2289,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
665,2300,1,3,,855772,689043,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
666,2313,1,1,,85787363,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
667,2314,1,2,,855772,689043,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
668,2314,1,2,,855772,689043,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
669,2315,1,2,,855772,689043,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
670,2315,1,2,,855772,689043,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
671,2316,1,1,,85787363,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
672,2322,1,1,,85787363,689043,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
673,2323,1,1,,50104061,689043,Inactive,254220970.0,,,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
674,2326,1,1,,855772,689043,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
675,2326,1,1,,50104061,689043,Inactive,194352380.0,,,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
676,2330,1,1,,85787363,689043,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
677,2353,1,3,,50104061,689043,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
678,2364,1,2,,50104061,689043,Inactive,4557365.0,641.0,,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
679,2380,1,2,,855772,689043,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
680,2391,1,1,,855772,689043,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
681,2417,1,1,,855772,689043,Inactive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
682,2435,1,2,,855772,689043,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
683,2445,1,2,,855772,689043,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
684,2451,1,2,,855772,689043,Inconclusive,122920737.0,,35.3973,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
685,2451,1,2,,26746990,689043,Inconclusive,122920737.0,,7.0627,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
686,2451,1,2,,26751505,689043,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
687,2451,1,2,,50104061,689043,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
688,2451,1,2,,50104062,689043,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
689,2451,1,2,,50104063,689043,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
690,2462,1,1,,855772,689043,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
691,2462,1,1,,855772,689043,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
692,2472,1,2,,855772,689043,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
693,2472,1,2,,26746990,689043,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
694,2472,1,2,,26751505,689043,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
695,2472,1,2,,50104062,689043,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
696,2472,1,2,,50104063,689043,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
697,2501,1,1,,855772,689043,Active,,,6.76,IC50,"A biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to identify compounds that inhibit the ATPase activity of Tag - Counter Screen",Confirmatory,,
698,2517,2,1,,855772,689043,Inconclusive,6980812.0,,14.1254,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
699,2517,2,1,,26746990,689043,Inconclusive,6980812.0,,3.1623,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
700,2517,2,1,,26751505,689043,Inconclusive,6980812.0,,14.1254,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
701,2517,2,1,,50104061,689043,Inconclusive,6980812.0,,44.6684,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
702,2517,2,1,,50104062,689043,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
703,2517,2,1,,50104063,689043,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
704,2520,1,4,,855772,689043,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
705,2521,1,3,,855772,689043,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
706,2523,1,1,,855772,689043,Inactive,124486680.0,16408.0,,,HTS of MLPCN Validation Compound Set for developing T Cell Immune Modulators,Screening,,
707,2524,1,2,,855772,689043,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
708,2528,1,2,,855772,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
709,2528,1,2,,26746990,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
710,2528,1,2,,26751505,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
711,2528,1,2,,50104061,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
712,2528,1,2,,50104062,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
713,2528,1,2,,50104063,689043,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
714,2540,1,2,,855772,689043,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
715,2544,1,2,,855772,689043,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
716,2546,1,1,,855772,689043,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
717,2546,1,1,,26746990,689043,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
718,2546,1,1,,26751505,689043,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
719,2546,1,1,,50104062,689043,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
720,2546,1,1,,50104063,689043,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
721,2549,1,1,,855772,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
722,2549,1,1,,26746990,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
723,2549,1,1,,26751505,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
724,2549,1,1,,50104061,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
725,2549,1,1,,50104062,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
726,2549,1,1,,50104063,689043,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
727,2550,1,3,,855772,689043,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
728,2551,1,1,,855772,689043,Inconclusive,188536040.0,19885.0,12.5893,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
729,2551,1,1,,26746990,689043,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
730,2551,1,1,,26751505,689043,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
731,2551,1,1,,50104062,689043,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
732,2551,1,1,,50104063,689043,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
733,2553,1,2,,855772,689043,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
734,2557,1,3,,855772,689043,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
735,2563,1,1,,855772,689043,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
736,2564,1,1,,26751505,689043,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay,Confirmatory,,
737,2565,1,1,,26751505,689043,Inactive,405898.0,,14.1254,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
738,2572,1,1,,26751505,689043,Inconclusive,6980812.0,,35.4813,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
739,2573,1,1,,26751505,689043,Inactive,6980812.0,,,Potency,qHTS FP-Based Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
740,2599,1,2,,855772,689043,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
741,2606,1,2,,855772,689043,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
742,2629,1,1,,855772,689043,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
743,2629,1,1,,56422203,689043,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
744,2642,1,2,,855772,689043,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
745,2648,1,2,,855772,689043,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
746,2650,2,1,,855772,689043,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
747,2660,1,1,,90340699,689043,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
748,2661,1,1,,855772,689043,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
749,2662,2,1,,855772,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
750,2662,2,1,,85231345,689043,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
751,2666,1,1,,90340699,689043,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
752,2667,1,1,,90340699,689043,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
753,2668,1,1,,90340699,689043,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
754,2674,1,1,,855772,689043,Inactive,34810098.0,,,,HTS for Identification of VLA-4 Allosteric Modulators from Validation Compound Set.,Screening,,
755,2675,1,1,,855772,689043,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
756,2675,1,1,,50104061,689043,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
757,2676,1,2,,855772,689043,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
758,2685,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
759,2690,1,2,,855772,689043,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
760,2706,1,1,,855772,689043,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide for Validation Compound Set,Screening,,
761,2716,1,1,,855772,689043,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
762,2716,1,1,,56422203,689043,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
763,2717,1,2,,855772,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
764,2718,1,1,,855772,689043,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
765,2732,1,1,,855772,689043,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
766,2732,1,1,,17404771,689043,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
767,2751,2,2,,855772,689043,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
768,2774,1,3,,92303701,689043,Inactive,,,,,LOPAC Circadian Assay,Screening,,
769,2796,1,4,,855772,689043,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
770,2797,1,2,,855772,689043,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
771,2805,2,2,,855772,689043,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
772,2806,2,2,,855772,689043,Active,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
773,2825,1,2,,855772,689043,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
774,6820,11,1,,103198532,689043,Active,,,43.0,IC50,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,Confirmatory,8254620.0,
775,6953,9,2,,103198532,689043,Active,,,16.7,IC50,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte,Confirmatory,2465410.0,
776,6960,3,7,,103198532,689043,Unspecified,,,,,Inhibitory activity against 5-lipoxygenase in guinea pig leukocyte at 30 uM,Other,2465410.0,
777,69555,9,2,,103198532,689043,Unspecified,,,1200.0,IC50,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Confirmatory,2552117.0,
778,69576,9,2,,103198532,689043,Unspecified,,,400.0,Ki,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Confirmatory,2552117.0,
779,91578,4,9,,103198532,689043,Unspecified,82312013.0,,,,Inhibition of Human Immunodeficiency Virus Type 1 integrase (HIV-1 IN) in the disintegration reaction at a concentration of 25 uM,Other,9986720.0,
780,104233,7,1,,103198532,689043,Unspecified,,,,,Lethal dose (LD5) concentration inhibiting growth of MT-2 cells by 5%,Other,9986720.0,
781,106907,8,1,,103198532,689043,Unspecified,,,1389.0,ED50,Concentration that inhibits Human Immunodeficiency Virus Type 1 (HIV-1)-induced death of MT-2 cells,Confirmatory,9986720.0,
782,125798,6,2,,103198532,689043,Active,,,3.3,IC50,Evaluated for the antioxidant property by measuring the inhibition of microsomal lipid peroxidation,Confirmatory,11206462.0,
783,144378,5,7,,103198532,689043,Inactive,1172801.0,12972.0,,,Tested for its ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells;Inactive,Other,9857096.0,
784,158873,8,1,,103198532,689043,Unspecified,,,122.0,IC50,In vitro antimalarial activity against Plasmodium falciparum,Confirmatory,7608896.0,
785,161179,3,7,,103198532,689043,Unspecified,,,,,Inhibition of cyclooxygenase activity in sheep seminal vesicle was determined at 10E-4 M,Other,8254620.0,
786,166551,3,4,,103198532,689043,Unspecified,,,,,Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control,Other,12951092.0,
787,216251,7,1,,103198532,689043,Inactive,,,,,In vitro inhibitory activity against the growth of WISH cell derived from human cervical carcinoma was determined; Inactive,Other,14684314.0,
788,226172,3,8,,103198532,689043,Unspecified,,,,,Compound was evaluated for inhibition of xanthine oxidase,Other,,
789,226669,6,3,,103198532,689043,Active,,,0.5,IC50,Compound was evaluated for hydroxyl radical (OH) scavenging activity,Confirmatory,,
790,226671,6,3,,103198532,689043,Unspecified,,,95.0,IC50,Superoxide anion (O2-) scavenging activity,Confirmatory,,
791,248765,9,1,,103198532,689043,Unspecified,,,100.0,IC50,Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages,Confirmatory,15780639.0,
792,252044,3,3,,103198532,689043,Unspecified,,,,,Percent inhibition of nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages at 100 uM of compound,Other,15780639.0,
793,254899,9,2,,103198532,689043,Active,,,3.0,IC50,In vitro inhibitory activity against 5-lipoxygenase obtained from potato,Confirmatory,16143531.0,
794,256502,3,4,,103198532,689043,Unspecified,,,,,Percent heme protein dependent lipid peroxidation at (1 mM) upon incubation for 10 min at 37 degree C. in pH 7.4 with arachidonic acid and H2O2,Other,16190766.0,
795,256505,7,1,,103198532,689043,Inactive,,,,,Percent heme protein dependent lipid peroxidation (0.1 mM) upon incubation for 10 min at 37 degree C. in pH 7.4 with arachidonic acid and H2O2; no action,Other,16190766.0,
796,256506,3,5,,103198532,689043,Unspecified,,,,,"Superoxide radical scavenging activity at 1 mM upon incubation for 2 min at RT in pH 7.4 with PMS, NADH and NBT by nitroblue tetrazolium method",Other,16190766.0,
797,257903,7,1,,103198532,689043,Active,,,,,Antioxidant potency assessed chemically,Other,16392814.0,
798,257904,6,2,,103198532,689043,Inactive,,,,IC50,Activity against hydrogen peroxide induced DNA damage in Jurkat T cells,Confirmatory,16392814.0,
799,257905,6,2,,103198532,689043,Unspecified,,,10000.0,EC50,Inhibition of glutamate-induced oxytosis of mouse hippocampal HT22 cells,Confirmatory,16392814.0,
800,261406,9,5,,103198532,689043,Active,75278003.0,,3.0,IC50,Inhibitory activity against potato 5LOX,Confirmatory,16509583.0,
801,261409,6,2,,103198532,689043,Unspecified,,,,,"Anti-inflammatory activity against carrageenan-induced edema in Sprague-Dawley rat paw after 3 hrs of 30 mg/kg, po",Other,16509583.0,
802,261410,3,3,,103198532,689043,Unspecified,,,,,"Inhibitory activity against 4% NaCl-induced abdominal constriction in Sprague-Dawley rat after 30 min of 30 mg/kg, po",Other,16509583.0,
803,261411,3,3,,103198532,689043,Unspecified,,,,,"Inhibitory activity against 4% NaCl-induced abdominal constriction in Sprague-Dawley rat after 60 min of 30 mg/kg, po",Other,16509583.0,
804,263688,5,8,,103198532,689043,Unspecified,401235.0,7299.0,,,Inhibitory activity against tyrosinase at 100uM,Other,16442796.0,
805,263926,6,2,,103198532,689043,Active,,,2.9,IC50,Superoxide radical scavenging activity,Confirmatory,16488146.0,
806,263927,6,2,,103198532,689043,Active,,,2.8,IC50,ABTS radical scavenging activity,Confirmatory,16488146.0,
807,263928,6,2,,103198532,689043,Active,,,31.7,IC50,DPPH radical scavenging activity,Confirmatory,16488146.0,
808,276002,6,2,,103198532,689043,Active,,,2.8,IC50,ABTS radical scavenging activity,Confirmatory,16908141.0,
809,276003,6,2,,103198532,689043,Active,,,2.9,IC50,Superoxide anion radical scavenging activity by xanthine/xanthine oxidase method,Confirmatory,16908141.0,
810,276004,6,2,,103198532,689043,Active,,,30.0,IC50,DPPH radical scavenging activity,Confirmatory,16908141.0,
811,276460,7,2,,103198532,689043,Unspecified,,,110000.0,EC50,DPPH radical scavenging activity,Confirmatory,16950623.0,
812,283976,6,2,,103198532,689043,Active,,,2.78,EC50,Antibacterial activity against Staphylococcus epidermidis,Confirmatory,17035037.0,
813,283977,6,2,,103198532,689043,Active,,,2.78,EC50,Antibacterial activity against Staphylococcus aureus,Confirmatory,17035037.0,
814,287995,6,3,,103198532,689043,Active,,,3.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,17387019.0,
815,287996,6,2,,103198532,689043,Active,,,2.2,IC50,Antioxidant activity assessed as superoxide radical anion scavenging activity,Confirmatory,17387019.0,
816,287997,6,2,,103198532,689043,Active,,,25.9,IC50,Antioxidant activity assessed as ABTS radical scavenging activity,Confirmatory,17387019.0,
817,289274,3,3,,103198532,689043,Unspecified,,,,,Inhibition of heme-dependent lipid peroxidation,Other,17604175.0,
818,289275,3,3,,103198532,689043,Unspecified,,,,,Superoxide radical scavenging activity at 0.1 mM,Other,17604175.0,
819,299820,9,2,,103198532,689043,Inactive,,,,IC50,Inhibition of PTP1B by colorimetric assay,Confirmatory,17596944.0,
820,303031,9,5,,103198532,689043,Unspecified,126398.0,547923.0,600.0,IC50,Inhibition of soybean lipoxygenase,Confirmatory,17942306.0,
821,303037,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 0.1 mM by nitroblue tetrazolium method,Other,17942306.0,
822,303902,3,3,,103198532,689043,Unspecified,,,,,Ratio of IC50 for drug to trolox for DPPH radical scavenging activity,Other,17980585.0,
823,303903,3,3,,103198532,689043,Unspecified,,,,,Ratio of IC50 for drug to trolox for ABTS radical scavenging activity,Other,17980585.0,
824,303904,6,2,,103198532,689043,Active,,,10.2,IC50,Antioxidant activity assessed as superoxide radical scavenging activity by xanthine oxidase method,Confirmatory,17980585.0,
825,307315,6,2,,103198532,689043,Unspecified,,,500.0,IC50,Inhibition of p56lck SH2 domain by ELISA,Confirmatory,17418581.0,
826,307316,3,4,,103198532,689043,Unspecified,,,,,Inhibition of Jurkat cell activation assessed as blocking of T-cell antigen receptor-induced IL-2 expression at 10 uM by luciferase assay,Other,17418581.0,
827,309363,3,3,,103198532,689043,Unspecified,,,,,Antiinflammatory activity in CD1 mouse assessed as inhibition of croton oil-induced ear oedema at 0.3 umol/cm^2 after 6 hrs,Other,17768049.0,
828,320801,3,3,,103198532,689043,Unspecified,,,,,Inhibition of beta amyloid 25-35 fibril formation at 10 uM,Other,18042380.0,
829,336478,3,7,,103198532,689043,Unspecified,,,,,Inhibition of COX2 at 100 uM by scintillation proximity assay,Other,12444669.0,
830,336481,3,7,,103198532,689043,Inactive,,,,,Inhibition of COX2 at 10 uM by scintillation proximity assay,Other,12444669.0,
831,338030,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 0.01 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
832,338031,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 0.1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
833,338032,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
834,338033,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic oxaloacetic transaminase release at 3 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
835,338034,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 0.01 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
836,338035,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 0.1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
837,338036,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamate pyruvate transaminase release at 1 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
838,338037,3,7,,103198532,689043,Unspecified,,,,,Hepatoprotective activity against carbon tetrachloride-induced hepatotoxicity in fasted Sprague-Dawley rat hepatocytes assessed as serum glutamic pyruvate transaminase release at 3 mg/ml administered before 10 mins of carbon tetrachloride challenge measured after 30 mins,Other,3430163.0,
839,338039,8,1,,103198532,689043,Unspecified,,,,,Effect on glutamate oxaloacetic transaminase activity at 1 mg/ml,Other,3430163.0,
840,338042,8,1,,103198532,689043,Unspecified,,,,,Effect on glutamic pyruvate transaminase activity at 1 mg/ml,Other,3430163.0,
841,340665,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents at 0.2 to 1 uM by ORAC-fluorescein assay,Other,18611049.0,
842,355327,3,3,,103198532,689043,Unspecified,,,,,Inhibition of HIV reverse transcriptase at 200 ug/ml,Other,9392884.0,
843,356737,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay,Other,11473417.0,
844,357270,3,4,,103198532,689043,Unspecified,,,,,Formation of 15HETE in A-23187-stimulated human polymorphonuclear leukocytes at 100 uM relative to control,Other,2822857.0,
845,357271,3,4,,103198532,689043,Unspecified,,,,,Formation of 15HETE in A-23187-stimulated human polymorphonuclear leukocytes at 1000 uM relative to control,Other,2822857.0,
846,357272,6,4,,103198532,689043,Unspecified,,,411.0,IC50,Inhibition of A23187-induced LTB4 formation in human polymorphonuclear leukocytes,Confirmatory,2822857.0,
847,357273,6,4,,103198532,689043,Unspecified,,,,IC50,"Inhibition of A23187-induced 12-hydroxy-5,8,10-heptadecatrienoic acid formation in human polymorphonuclear leukocytes",Confirmatory,2822857.0,
848,357274,6,4,,103198532,689043,Unspecified,,,276.0,IC50,Inhibition of A23187-induced 5HETE formation in human polymorphonuclear leukocytes,Confirmatory,2822857.0,
849,357278,3,4,,103198532,689043,Active,,,,,Enhancement of PGE2 formation in A-23187-stimulated human polymorphonuclear leukocytes at 100 to 1000 uM,Other,2822857.0,
850,357279,4,5,,103198532,689043,Active,,,,,"Inhibition of A23187-induced 12-hydroxy-5,8,10-heptadecatrienoic acid formation in human polymorphonuclear leukocytes at 1000 uM",Other,2822857.0,
851,357280,3,4,,103198532,689043,Active,,,,,Enhancement of PGE2 formation in A-23187-stimulated human polymorphonuclear leukocytes at 10 to 100 uM,Other,2822857.0,
852,357281,3,4,,103198532,689043,Active,,,,,Enhancement of 15HETE formation in A-23187-stimulated human polymorphonuclear leukocytes at 10 to 100 uM,Other,2822857.0,
853,357282,4,5,,103198532,689043,Active,,,,,Inhibition of A23187-induced 5HETE formation in human polymorphonuclear leukocytes at 1 to 1000 uM,Other,2822857.0,
854,357288,3,4,,103198532,689043,Unspecified,,,,,Cytotoxicity against human polymorphonuclear leukocytes assessed as occurrence of cell suspension or lactate dehydrogenase release at 1 to 1000 uM,Other,2822857.0,
855,357289,3,4,,103198532,689043,Unspecified,,,,,Formation of 15HETE in A-23187-stimulated human polymorphonuclear leukocytes at 10 uM relative to control,Other,2822857.0,
856,357365,6,3,,103198532,689043,Unspecified,,,66.7,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins,Confirmatory,11520237.0,
857,358171,14,2,,103198532,689043,Unspecified,2811086.0,1956.0,1000.0,IC50,Inhibition of EGFR in human A431 cells,Confirmatory,1479375.0,
858,362056,6,2,,103198532,689043,Unspecified,,,3406.0,EC50,Cytotoxicity against mouse RAW264.7 cells assessed as cell survival after 24 hrs by MTT assay,Confirmatory,18667320.0,
859,362057,6,2,,103198532,689043,Unspecified,,,165.295,EC50,Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite accumulation administered 1 hr before LPS challenge and measured after 24 hrs by Griess reagent assay,Confirmatory,18667320.0,
860,362058,3,4,,103198532,689043,Unspecified,,,,,Ratio of EC50 for mouse RAW264.7 cells to EC50 for inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells,Other,18667320.0,
861,362059,7,1,,103198532,689043,Active,,,,,Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite level at 1 uM administered 1 hr before LPS challenge and measured after 24 hrs by Griess reagent assay,Other,18667320.0,
862,362060,3,4,,103198532,689043,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as survival at 1 uM after 24 hrs by MTT assay,Other,18667320.0,
863,362061,7,1,,103198532,689043,Active,,,,,Effect on nitric oxide production in mouse RAW264.7 cells assessed as nitrite level at 1 uM after 24 hrs by Griess reagent assay,Other,18667320.0,
864,362184,6,2,,103198532,689043,Active,,,2.8,IC50,Inhibition of HIV1 integrase by overall integration assay,Confirmatory,18674899.0,
865,362185,6,2,,103198532,689043,Active,,,24.0,IC50,Inhibition of HIV1 integrase strand transfer activity,Confirmatory,18674899.0,
866,362190,6,2,,103198532,689043,Active,,,2.8,IC50,Inhibition of HIV1 integrase in presence of Mn2+,Confirmatory,18674899.0,
867,368227,6,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato LOX5,Confirmatory,19136259.0,
868,371216,6,2,,103198532,689043,Unspecified,,,100.0,IC50,Inhibition of HIV1 integrase by ELISA,Confirmatory,18952420.0,
869,375988,6,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity relative to control,Other,16643034.0,
870,375989,6,2,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide anion scavenging activity by xanthine oxidase oxidation system relative to control,Other,16643034.0,
871,375991,3,3,,103198532,689043,Unspecified,,,,,"Antioxidant activity assessed as inhibition of 2,2'-azobis(2-amidinopropane)dihydrochloride-induced lipid peroxidation at 3.125 ug/ml by ferric thiocyanate system relative to control",Other,16643034.0,
872,375992,7,2,,103198532,689043,Inconclusive,,,,,Inhibition of HIV1 recombinant integrase expressed in Escherichia coli,Other,16643034.0,
873,378763,7,1,,103198532,689043,Inactive,,,,,Induction of resting HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
874,378764,4,3,,103198532,689043,Inactive,,,,,Induction of phytohemagglutininin-activated HMNC proliferation assessed as [3H]thymidine uptake at 10 ug/mL after 3 days by lymphoproliferation test relative to control,Other,10096846.0,
875,378767,7,1,,103198532,689043,Inactive,,,,,Immunomodulatory activity in resting HMNC assessed as IFN-gamma production at 10 ug/mL after 3 days by EIA realtive to control,Other,10096846.0,
876,378768,3,4,,103198532,689043,Inactive,,,,,Immunomodulatory activity in phytochemagglutininin-stimulatedHMNC assessed as IFN-gamma production at 10 ug/mL after 3 days by EIA realtive to control,Other,10096846.0,
877,378799,3,3,,103198532,689043,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity index,Other,16989539.0,
878,379089,6,2,,103198532,689043,Unspecified,,,553.8,IC50,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay,Confirmatory,10096863.0,
879,379092,3,4,,103198532,689043,Active,,,,,Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay,Other,10096863.0,
880,380004,7,2,,103198532,689043,Unspecified,,,,,Cytotoxicity against mouse P388 cells after 72 hrs by MTT assay,Other,10785435.0,
881,385427,3,3,,103198532,689043,Unspecified,,,,,Inhibition of soybean 15-lipoxygenase,Other,18314336.0,
882,392741,5,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 100 uM by nitroblue tetrazolium method,Other,19150597.0,
883,392749,6,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean lipoxygenase by UV absorbance based assay,Confirmatory,19150597.0,
884,392757,9,5,,103198532,689043,Active,126407.0,240.0,25.0,IC50,Inhibition of human 5LOX expressed in HEK293 cells,Confirmatory,19152786.0,
885,393821,6,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato 5LOX by enzyme immunoassay,Confirmatory,19296694.0,
886,395150,9,1,,103198532,689043,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity,Other,18403057.0,
887,397153,11,1,,103198532,689043,Unspecified,,,,,Antioxidant activity against Cu2+-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before Cu2+ challenge,Other,11325231.0,
888,397154,8,1,,103198532,689043,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation in human plasma LDL preincubated for 1 hr before AAPH challenge,Other,11325231.0,
889,397183,3,3,,103198532,689043,Unspecified,,,,,DPPH radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 50 uM after 40 mins,Other,19058883.0,
890,397184,3,3,,103198532,689043,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 50 uM by spectrophotometric analysis,Other,19058883.0,
891,397185,3,3,,103198532,689043,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,19058883.0,
892,397586,3,9,,103198532,689043,Unspecified,2497687.0,7941.0,,,Effect on human plasma LDL-PLA2 activity by LS-3B fluorescence spectrometry,Other,11325231.0,
893,397831,4,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
894,401061,6,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,9599286.0,
895,402013,6,2,,103198532,689043,Unspecified,,,82.7,IC50,Inhibition of collagenase type 5,Confirmatory,15921434.0,
896,410035,6,2,,103198532,689043,Active,,,3.47,IC50,Inhibition of potato LOX5 by enzyme immuno assay,Confirmatory,18945614.0,
897,427136,6,2,,103198532,689043,Active,,,5.37,IC50,Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins by cation decolorization assay,Confirmatory,19450986.0,
898,427137,6,2,,103198532,689043,Unspecified,,,58.0,IC50,Antioxidant activity assessed as superoxide radical anion scavenging activity after 30 mins by xanthine/xanthine oxidase method,Confirmatory,19450986.0,
899,427138,6,3,,103198532,689043,Active,,,21.11,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,19450986.0,
900,431302,9,1,,103198532,689043,Unspecified,,,,,Inhibition of soybean lipoxygenase,Other,19581098.0,
901,434955,1,2,,855772,689043,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
902,434959,1,1,,85787363,689043,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
903,434962,1,2,,855772,689043,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
904,434970,1,2,,855772,689043,Inactive,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
905,434971,1,2,,855772,689043,Active,124487323.0,76768.0,,,Single concentration confirmation of uHTS hits from a small molecule inhibitors of mouse intestinal alkaline phosphatase via a luminescent assay,Screening,,
906,434973,1,3,,855772,689043,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
907,434989,1,1,,855772,689043,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
908,435003,1,3,,855772,689043,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
909,435005,1,1,,855772,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
910,435022,2,2,,855772,689043,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
911,435030,1,2,,855772,689043,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
912,435030,1,2,,855772,689043,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
913,440886,5,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean lipoxygenase assessed as conversion of sodium linoleate to 13-hydroperoxylinoleic acid,Confirmatory,19781823.0,
914,440887,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity at 0.1 mM after 2 mins by nitroblue tetrazolium method,Other,19781823.0,
915,442506,3,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 20 mins by spectrophotometry,Other,19939514.0,
916,442507,3,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 100 uM,Other,19939514.0,
917,442508,8,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean lipoxygenase assessed as conversion of sodium linoleate to 13-hydroperoxylinoleate,Confirmatory,19939514.0,
918,443492,3,3,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for ovine COX-1 to IC50 for ovine COX-2,Other,19880317.0,
919,443728,8,5,,103198532,689043,Active,75278003.0,,4.0,IC50,Inhibition of potato 5-LOX after 5 mins by enzyme immuno assay,Confirmatory,19884005.0,
920,447578,3,4,,103198532,689043,Unspecified,2498443.0,3065.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
921,447578,3,4,,103198532,689043,Unspecified,3334210.0,8841.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
922,447578,3,4,,103198532,689043,Unspecified,19865267.0,9734.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
923,447578,3,4,,103198532,689043,Unspecified,26394832.0,79885.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
924,447578,3,4,,103198532,689043,Unspecified,27734403.0,83933.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
925,447578,3,4,,103198532,689043,Unspecified,29839394.0,55869.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
926,447578,3,4,,103198532,689043,Unspecified,30913097.0,51564.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
927,447578,3,4,,103198532,689043,Unspecified,68068066.0,3066.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
928,447578,3,4,,103198532,689043,Unspecified,205371758.0,10013.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
929,447578,3,4,,103198532,689043,Unspecified,259016348.0,9759.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
930,447578,3,4,,103198532,689043,Unspecified,296434519.0,10014.0,,,Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay,Other,19520580.0,
931,447579,8,1,,103198532,689043,Unspecified,2498443.0,3065.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
932,447579,8,1,,103198532,689043,Unspecified,3334210.0,8841.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
933,447579,8,1,,103198532,689043,Unspecified,19865267.0,9734.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
934,447579,8,1,,103198532,689043,Unspecified,26394832.0,79885.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
935,447579,8,1,,103198532,689043,Unspecified,27734403.0,83933.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
936,447579,8,1,,103198532,689043,Unspecified,29839394.0,55869.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
937,447579,8,1,,103198532,689043,Unspecified,30913097.0,51564.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
938,447579,8,1,,103198532,689043,Unspecified,68068066.0,3066.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
939,447579,8,1,,103198532,689043,Unspecified,205371758.0,10013.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
940,447579,8,1,,103198532,689043,Unspecified,259016348.0,9759.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
941,447579,8,1,,103198532,689043,Unspecified,296434519.0,10014.0,2540.0,IC50,Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay,Confirmatory,19520580.0,
942,449328,3,4,,103198532,689043,Active,,,,,Antioxidant activity assessed as DPPH radical scavenging activity by UV-visible spectrophotometry,Other,19674895.0,
943,449642,3,3,,103198532,689043,Unspecified,,,,,"Antinociceptive activity in Swiss mouse by inhibition of acetic acid-induced abdominal constriction at 10 mg/kg, ip after 20 mins",Other,19628311.0,
944,449663,3,3,,103198532,689043,Unspecified,,,,,"Lipophilicity, log P of the compound",Other,19628311.0,
945,449728,1,2,,855772,689043,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
946,449739,1,2,,855772,689043,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
947,449762,1,2,,855772,689043,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
948,449763,1,3,,855772,689043,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
949,449768,1,1,,855772,689043,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
950,452851,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging activity at 10 uM,Other,19853459.0,
951,452855,5,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean 5-lipoxygenase by UV-absorbance based enzyme assay,Confirmatory,19853459.0,
952,456268,6,2,,103198532,689043,Unspecified,,,,,Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA,Other,19942440.0,
953,461096,5,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato tuber 5LOX by polarographic method,Confirmatory,20045317.0,
954,461114,5,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato 5-Lipoxygenase by enzyme immuno assay,Confirmatory,20045320.0,
955,461117,3,3,,103198532,689043,Unspecified,,,,,"Antiinflammatory activity against carrageenan-induced paw edema in rat at 30 mg/kg, po",Other,20045320.0,
956,462270,8,5,,103198532,689043,Active,115449.0,759.0,2.38,Ki,Inhibition of human CA1 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
957,462271,8,5,,103198532,689043,Active,115456.0,760.0,1.61,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
958,462272,8,5,,103198532,689043,Active,134047703.0,761.0,10.0,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
959,462273,8,5,,103198532,689043,Active,115465.0,762.0,10.1,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
960,462274,8,5,,103198532,689043,Active,461680.0,763.0,6.49,Ki,Inhibition of human CA5A by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
961,462275,8,5,,103198532,689043,Active,8928041.0,11238.0,9.08,Ki,Inhibition of human CA5B by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
962,462276,8,5,,103198532,689043,Active,116241278.0,765.0,7.33,Ki,Inhibition of human CA6 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
963,462277,8,5,,103198532,689043,Active,1168744.0,766.0,6.42,Ki,Inhibition of human CA7 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
964,462278,8,5,,103198532,689043,Active,83300925.0,768.0,7.87,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
965,462279,8,5,,103198532,689043,Active,5915866.0,771.0,9.06,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
966,462280,8,5,,103198532,689043,Active,30580372.0,71934.0,10.9,Ki,Inhibition of mouse CA13 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
967,462281,8,5,,103198532,689043,Active,8928036.0,23632.0,8.71,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,Confirmatory,20185318.0,
968,463073,1,2,,855772,689043,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4),Screening,,
969,463075,1,1,,855772,689043,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
970,463079,1,2,,855772,689043,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
971,463082,1,1,,855772,689043,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
972,463096,1,1,,50104061,689043,Inactive,,,,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
973,463097,1,1,,50104061,689043,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
974,463104,1,2,,855772,689043,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
975,463106,1,2,,90340699,689043,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
976,463111,1,1,,855772,689043,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
977,463115,1,1,,855772,689043,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
978,463141,1,2,,855772,689043,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
979,463165,1,1,,855772,689043,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
980,463187,1,1,,855772,689043,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
981,463189,1,1,,855772,689043,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
982,463189,1,1,,53777314,689043,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
983,463190,1,2,,855772,689043,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
984,463193,1,1,,855772,689043,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
985,463195,1,2,,855772,689043,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
986,463210,1,2,,855772,689043,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
987,463212,1,1,,855772,689043,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
988,463254,1,1,,855772,689043,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
989,465832,3,3,,103198532,689043,Inactive,,,,,Hepatoprotective activity in rat WB-F344 cells assessed as inhibition of D-galactosamine-induced cytotoxicity at 10 uM after 1 hrs by MTT assay relative to control treated before D-galactosamine challenge,Other,20092289.0,
990,467251,8,5,,103198532,689043,Active,131467.0,5770.0,3.06,IC50,Inhibition of human recombinant PTP1B after 10 mins,Confirmatory,19476336.0,
991,469911,5,3,,103198532,689043,Active,,,17.8,EC50,Antioxidant activity assessed as DPPH radical scavenging activity,Confirmatory,19653667.0,
992,471739,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 100 uM by nitroblue tetrazolium method,Other,19811914.0,
993,474249,5,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato 5LOX by enzyme immuno assay,Confirmatory,20202839.0,
994,477408,5,4,,103198532,689043,Unspecified,,,2000.0,IC50,Inhibition of hyaluronidase,Confirmatory,20184336.0,
995,485270,1,1,,855772,689043,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
996,485272,1,1,,855772,689043,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
997,485273,2,1,,855772,689043,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
998,485275,1,3,,855772,689043,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
999,485281,1,1,,855772,689043,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1000,485290,1,1,,855772,689043,Inconclusive,20150581.0,,44.6684,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1001,485290,1,1,,26746990,689043,Inconclusive,20150581.0,,6.3096,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1002,485290,1,1,,26751505,689043,Inconclusive,20150581.0,,0.7943,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1003,485290,1,1,,50104061,689043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1004,485290,1,1,,50104062,689043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1005,485290,1,1,,50104063,689043,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1006,485294,1,1,,855772,689043,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
1007,485295,1,2,,90340699,689043,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
1008,485297,1,1,,855772,689043,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1009,485297,1,1,,90340699,689043,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1010,485298,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1011,485298,1,1,,90340699,689043,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1012,485313,1,2,,855772,689043,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1013,485313,1,2,,90340699,689043,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1014,485314,1,1,,855772,689043,Inconclusive,4505931.0,5423.0,15.8489,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1015,485314,1,1,,50104061,689043,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1016,485317,1,2,,855772,689043,Active,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
1017,485341,1,1,,855772,689043,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
1018,485342,1,2,,90340699,689043,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1019,485344,1,1,,855772,689043,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
1020,485345,1,2,,90340699,689043,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1021,485346,1,1,,855772,689043,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1022,485346,1,1,,855772,689043,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1023,485347,1,2,,855772,689043,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
1024,485353,2,1,,855772,689043,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
1025,485358,1,1,,855772,689043,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
1026,485360,1,1,,855772,689043,Inconclusive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
1027,485364,1,1,,855772,689043,Inconclusive,15149312.0,8345881.0,44.6684,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
1028,485366,1,2,,90340699,689043,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1029,485367,1,2,,855772,689043,Inconclusive,72386991.0,3656265.0,0.6012,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1030,485368,1,2,,90340699,689043,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1031,486725,6,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay,Other,20181415.0,
1032,486726,6,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Pseudomonas fluorescens ATCC 13525 after 24 hrs by MTT assay,Other,20181415.0,
1033,486727,6,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay,Other,20181415.0,
1034,486728,6,2,,103198532,689043,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 10231 after 48 hrs by MTT assay,Other,20181415.0,
1035,488645,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay,Other,20476748.0,
1036,488745,1,4,,85231345,689043,Inconclusive,,,0.2936,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1037,488752,1,4,,85231345,689043,Inactive,,,,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1038,488772,1,1,,90340699,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1039,488773,1,2,,90340699,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1040,488806,1,2,,855772,689043,Inactive,148539876.0,156.0,,,RNA aptamer-based validation for inhibitors of GRK2,Screening,,
1041,488816,1,1,,90340699,689043,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
1042,488837,1,1,,855772,689043,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1043,488837,1,1,,90340699,689043,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1044,488839,1,1,,56422203,689043,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1045,488839,1,1,,56422203,689043,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1046,488847,1,3,,855772,689043,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
1047,488862,1,1,,56422203,689043,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1048,488890,1,2,,855772,689043,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
1049,488895,1,2,,56422203,689043,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1050,488896,1,1,,56422203,689043,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1051,488899,1,1,,56422203,689043,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1052,488922,1,2,,855772,689043,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
1053,488949,1,2,,85231345,689043,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1054,488949,1,2,,90340699,689043,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1055,488953,1,1,,90340699,689043,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1056,488965,1,2,,56422203,689043,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1057,488966,1,1,,56422203,689043,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
1058,488975,1,2,,855772,689043,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
1059,488977,1,2,,855772,689043,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
1060,488978,1,1,,90340699,689043,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
1061,488979,1,1,,50104061,689043,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
1062,488980,1,1,,85231345,689043,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
1063,488981,1,1,,90340699,689043,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
1064,488982,1,1,,90340699,689043,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
1065,488983,1,1,,90340699,689043,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
1066,489030,2,1,,855772,689043,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
1067,489031,2,1,,855772,689043,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
1068,489698,3,5,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 25 uM after 20 mins relative to control,Other,20542693.0,
1069,490943,3,4,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 20 mins,Other,20434240.0,
1070,490944,3,4,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 50 uM after 60 mins,Other,20434240.0,
1071,490945,3,4,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 20 mins,Other,20434240.0,
1072,490946,3,4,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 100 uM after 60 mins,Other,20434240.0,
1073,490947,5,2,,103198532,689043,Unspecified,,,,,Inhibition of soybean LOX at 100 uM,Other,20434240.0,
1074,490948,4,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 10 uM,Other,20434240.0,
1075,490949,4,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as inhibition of lipid peroxidation at 100 uM,Other,20434240.0,
1076,492140,3,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay,Other,20565070.0,
1077,492947,1,1,,855772,689043,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1078,492953,1,1,,56422203,689043,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
1079,492956,1,1,,56422203,689043,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
1080,492972,1,1,,56422203,689043,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
1081,493005,1,1,,56422203,689043,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1082,493008,1,1,,56422203,689043,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1083,493008,1,1,,56422203,689043,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1084,493008,1,1,,56422203,689043,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1085,493008,1,1,,56422203,689043,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1086,493011,1,1,,855772,689043,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1087,493012,1,1,,855772,689043,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1088,493014,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1089,493027,1,2,,56422203,689043,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1090,493027,1,2,,56422203,689043,Inactive,223718203.0,5346.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1091,493035,1,2,,56422203,689043,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1092,493035,1,2,,56422203,689043,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1093,493036,1,2,,855772,689043,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
1094,493056,1,1,,855772,689043,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
1095,493084,1,1,,855772,689043,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
1096,493087,1,1,,56422203,689043,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
1097,493091,1,1,,56422203,689043,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
1098,493098,1,1,,56422203,689043,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
1099,493106,1,1,,90340699,689043,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1100,493107,1,1,,90340699,689043,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1101,493127,1,1,,50104061,689043,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
1102,493131,1,1,,56422203,689043,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
1103,493153,1,1,,90340699,689043,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1104,493153,1,1,,90340699,689043,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1105,493160,1,1,,56422203,689043,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
1106,493164,1,2,,90340699,689043,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1107,493164,1,2,,90340699,689043,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1108,493164,1,2,,90340699,689043,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1109,493187,1,2,,56422203,689043,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
1110,493189,1,1,,50104061,689043,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
1111,493244,1,1,,56422203,689043,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1112,493244,1,1,,56422203,689043,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1113,493244,1,1,,56422203,689043,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1114,493244,1,1,,56422203,689043,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1115,498706,3,3,,103198532,689043,Inactive,,,,,Inhibition of beta lactamase CTX-M assessed as hydrolysis of beta lactam up to 5 mM by spectrometry analysis,Other,19305397.0,
1116,499282,2,3,,103198532,689043,Unspecified,,,,,Redox potential at pH 7.3 by differential pulse and cyclic voltametry,Other,20650639.0,
1117,499283,2,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation in liposomes measured as Trolox equivalent antioxidant capacity,Other,20650639.0,
1118,499285,2,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as ratio of IC50 for Trolox to compound for ABTS radical scavenging activity after 5 mins by TEAC assay,Other,20650639.0,
1119,499286,2,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as ratio of IC50 for Trolox to compound for ABTS radical scavenging activity after 20 mins by TEAC assay,Other,20650639.0,
1120,499287,2,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as ratio of IC50 for Trolox to compound for DPPH radical scavenging activity by TEAC assay,Other,20650639.0,
1121,504326,1,2,,56422203,689043,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1122,504326,1,2,,56422203,689043,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1123,504327,1,1,,855772,689043,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1124,504327,1,1,,90340699,689043,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1125,504329,1,1,,56422203,689043,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
1126,504332,1,1,,855772,689043,Active,168985070.0,,11.2202,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1127,504332,1,1,,50104061,689043,Active,168985070.0,,3.1623,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1128,504332,1,1,,90340699,689043,Active,168985070.0,,10.6213,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1129,504333,1,1,,855772,689043,Inconclusive,6683500.0,29994.0,31.6228,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
1130,504339,1,1,,56422203,689043,Inconclusive,162330054.0,,56.2341,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
1131,504357,1,1,,56422203,689043,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1132,504357,1,1,,56422203,689043,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1133,504364,1,1,,85231345,689043,Inactive,7705682.0,51053.0,,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
1134,504406,1,1,,855772,689043,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
1135,504408,2,1,,855772,689043,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
1136,504411,1,1,,56422203,689043,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
1137,504414,1,1,,56422203,689043,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1138,504414,1,1,,56422203,689043,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1139,504423,1,1,,56422203,689043,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1140,504441,1,1,,56422203,689043,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1141,504444,1,1,,56422203,689043,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
1142,504454,1,3,,56422203,689043,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
1143,504462,1,1,,56422203,689043,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
1144,504466,1,1,,855772,689043,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1145,504467,1,1,,855772,689043,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1146,504490,1,2,,56422203,689043,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
1147,504523,1,1,,56422203,689043,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1148,504523,1,1,,56422203,689043,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1149,504536,1,1,,90340699,689043,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
1150,504541,1,1,,855772,689043,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Validation Set,Screening,,
1151,504547,1,1,,90340699,689043,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1152,504548,1,2,,90340699,689043,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
1153,504558,1,1,,56422203,689043,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1154,504577,2,2,,56422203,689043,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1155,504582,2,1,,56422203,689043,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1156,504594,1,1,,56422203,689043,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1157,504600,1,2,,855772,689043,Inactive,6325022.0,855842.0,,,Validation of HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1158,504621,1,1,,56422203,689043,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1159,504634,1,1,,56422203,689043,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1160,504648,1,1,,56422203,689043,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
1161,504651,1,1,,855772,689043,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
1162,504652,1,1,,855772,689043,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
1163,504660,1,1,,855772,689043,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
1164,504690,1,3,,56422203,689043,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
1165,504692,2,2,,56422203,689043,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1166,504700,1,1,,56422203,689043,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1167,504700,1,1,,56422203,689043,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1168,504706,1,1,,855772,689043,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
1169,504707,1,1,,56422203,689043,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1170,504707,1,1,,56422203,689043,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1171,504720,1,1,,56422203,689043,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
1172,504734,1,1,,56422203,689043,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
1173,504766,2,1,,56422203,689043,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
1174,504775,1,1,,56422203,689043,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
1175,504803,1,1,,56422203,689043,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
1176,504810,1,2,,855772,689043,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1177,504810,1,2,,90340699,689043,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1178,504812,1,2,,855772,689043,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1179,504812,1,2,,90340699,689043,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1180,504821,1,1,,85231345,689043,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
1181,504832,1,1,,855772,689043,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1182,504834,1,1,,855772,689043,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1183,504836,1,2,,90340699,689043,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
1184,504842,1,1,,855772,689043,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
1185,504845,1,1,,56422203,689043,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1186,504845,1,1,,90340699,689043,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1187,504847,1,1,,56422203,689043,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1188,504847,1,1,,90340699,689043,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1189,504865,1,1,,90340699,689043,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1190,504884,1,2,,56422203,689043,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1191,504891,1,1,,56422203,689043,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
1192,504894,1,1,,56422203,689043,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
1193,504937,1,2,,56422203,689043,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
1194,521220,3,3,,103198532,689043,Inactive,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
1195,540253,1,1,,56422203,689043,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1196,540253,1,1,,56422203,689043,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1197,540253,1,1,,56422203,689043,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1198,540256,1,2,,855772,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1199,540256,1,2,,50104061,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1200,540256,1,2,,90340699,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1201,540263,1,1,,56422203,689043,Inconclusive,5031833.0,10073.0,141.254,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1202,540263,1,1,,56422203,689043,Inconclusive,19923142.0,3837.0,141.254,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1203,540267,1,1,,56422203,689043,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
1204,540275,1,1,,855772,689043,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
1205,540276,1,2,,855772,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1206,540276,1,2,,26746990,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1207,540276,1,2,,26751505,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1208,540276,1,2,,50104061,689043,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1209,540276,1,2,,50104062,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1210,540276,1,2,,50104063,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1211,540276,1,2,,50104064,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1212,540276,1,2,,50104065,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1213,540276,1,2,,85231345,689043,Inconclusive,420597.0,,18.3564,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1214,540276,1,2,,90340699,689043,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1215,540277,1,1,,855772,689043,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
1216,540295,1,1,,56422203,689043,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
1217,540303,1,1,,56422203,689043,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1218,540303,1,1,,56422203,689043,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1219,540303,1,1,,56422203,689043,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1220,540308,1,1,,56422203,689043,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
1221,540317,1,1,,56422203,689043,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1222,540336,1,1,,56422203,689043,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1223,540336,1,1,,56422203,689043,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1224,540364,1,2,,56422203,689043,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
1225,548102,7,5,,103198532,689043,Unspecified,75319501.0,,600.0,IC50,Inhibition of soybean lipoxygenase at by UV spectrophotometry,Confirmatory,20888086.0,
1226,548956,4,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean lipoxygenase,Confirmatory,21041094.0,
1227,548959,3,5,,103198532,689043,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation assessed as inhibition of conjugated diene hydroperoxide production at 0.1 mM by UV spectrophotometry,Other,21041094.0,
1228,548960,1,4,,103198532,689043,Unspecified,,,,,Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 20 mins,Other,21041094.0,
1229,548961,1,4,,103198532,689043,Unspecified,,,,,Antioxidant activity of the compound assessed as reducing activity of DPPH at 0.1 mM after 60 mins,Other,21041094.0,
1230,549987,4,2,,103198532,689043,Active,,,17.8,IC50,Antileishmanial activity against Leishmania amazonensis MHOM/BR/76/LTB-012 axenic amastigotes after 72 hrs by MTT assay,Confirmatory,20954722.0,
1231,549988,4,2,,103198532,689043,Unspecified,,,550.0,IC50,Cytotoxicity against mouse peritoneal macrophages assessed as cell viability after 48 hrs by hematocytometer,Confirmatory,20954722.0,
1232,549989,4,2,,103198532,689043,Unspecified,,,550.0,IC50,Cytotoxicity against african green monkey Vero cells assessed as [3H]-hypoxanthine incorporation after 48 hrs,Confirmatory,20954722.0,
1233,549990,4,2,,103198532,689043,Unspecified,,,550.0,IC50,Cytotoxicity against human MCF7 cells assessed as [3H]-hypoxanthine incorporation after 48 hrs,Confirmatory,20954722.0,
1234,567038,4,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean LOX,Confirmatory,21106277.0,
1235,567042,1,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as Fe3+/ascorbic acid-induced superoxide anion radical scavenging activity at 0.1 mM,Other,21106277.0,
1236,568834,4,3,,103198532,689043,Active,,,34.1,IC50,Antioxidant activity assessed as residual DPPH radical scavenging activity after 45 mins by spectrophotometrically,Confirmatory,21216503.0,
1237,568835,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents of ABTS radical scavenging activity by TEAC assay,Other,21216503.0,
1238,578497,4,2,,103198532,689043,Active,,,4.5,IC50,Inhibition of potato 5-LOX assessed as hydroperoxides production by EIA,Confirmatory,21349729.0,
1239,588334,1,1,,56422203,689043,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
1240,588335,1,1,,56422203,689043,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
1241,588342,1,1,,855772,689043,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
1242,588349,1,1,,90340699,689043,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
1243,588352,1,2,,56422203,689043,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
1244,588354,1,1,,56422203,689043,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
1245,588358,1,2,,56422203,689043,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
1246,588368,1,2,,855772,689043,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies from validation set,Screening,,
1247,588378,1,1,,90340699,689043,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
1248,588379,1,2,,124883135,689043,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
1249,588391,1,1,,56422203,689043,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1250,588405,1,1,,56422203,689043,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
1251,588413,1,2,,56422203,689043,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
1252,588436,1,1,,56422203,689043,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
1253,588453,1,1,,56422203,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1254,588453,1,1,,85231345,689043,Inconclusive,8659577.0,58819.0,1.0621,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1255,588453,1,1,,90340699,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1256,588456,1,1,,56422203,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1257,588456,1,1,,90340699,689043,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1258,588458,1,1,,56422203,689043,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
1259,588459,1,2,,855772,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,16604538.0,
1260,588459,1,2,,855772,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20035615.0,
1261,588459,1,2,,855772,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20938917.0,
1262,588460,1,2,,855772,689043,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,16604538.0,
1263,588460,1,2,,855772,689043,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20035615.0,
1264,588460,1,2,,855772,689043,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20938917.0,
1265,588461,1,2,,855772,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,16604538.0,
1266,588461,1,2,,855772,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20035615.0,
1267,588461,1,2,,855772,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20938917.0,
1268,588473,1,1,,56422203,689043,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1269,588473,1,1,,56422203,689043,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1270,588475,1,2,,56422203,689043,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1271,588475,1,2,,56422203,689043,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1272,588478,1,2,,124801183,689043,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
1273,588489,1,1,,56422203,689043,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
1274,588492,1,1,,56422203,689043,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
1275,588493,1,2,,56422203,689043,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
1276,588497,1,2,,56422203,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
1277,588497,1,2,,56422203,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
1278,588497,1,2,,56422203,689043,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
1279,588499,1,3,,56422203,689043,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
1280,588499,1,3,,56422203,689043,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
1281,588499,1,3,,56422203,689043,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
1282,588501,1,2,,56422203,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
1283,588501,1,2,,56422203,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
1284,588501,1,2,,56422203,689043,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
1285,588506,1,2,,855772,689043,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors with Validation compound Set,Screening,,
1286,588511,1,2,,855772,689043,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
1287,588549,1,1,,56422203,689043,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1288,588550,1,1,,855772,689043,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for Validation Compound Set,Screening,,
1289,588579,1,1,,56422203,689043,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1290,588579,1,1,,90340699,689043,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1291,588579,1,1,,124883134,689043,Inconclusive,7705344.0,51426.0,28.1838,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1292,588579,1,1,,124883135,689043,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1293,588579,1,1,,124883138,689043,Inconclusive,7705344.0,51426.0,33.5875,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1294,588590,1,1,,50104061,689043,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1295,588590,1,1,,56422203,689043,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1296,588591,1,1,,50104061,689043,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1297,588591,1,1,,56422203,689043,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1298,588621,1,1,,56422203,689043,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1299,588627,1,1,,855772,689043,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1300,588664,1,2,,56422203,689043,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1301,588664,1,2,,56422203,689043,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1302,588674,1,2,,56422203,689043,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1303,588675,1,1,,855772,689043,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1304,588676,1,1,,855772,689043,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1305,588685,1,1,,855772,689043,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with Validation compound set,Screening,,
1306,588689,1,1,,56422203,689043,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1307,588692,2,1,,56422203,689043,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1308,588726,1,2,,56422203,689043,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1309,588727,1,1,,56422203,689043,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1310,588795,1,1,,56422203,689043,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1311,588795,1,1,,90340699,689043,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1312,588814,1,3,,56422203,689043,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1313,588819,1,4,,56422203,689043,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1314,588834,2,1,,50104061,689043,Inconclusive,325651834.0,3757.0,2.5119,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1315,588850,1,1,,56422203,689043,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1316,588852,1,3,,56422203,689043,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1317,588855,1,1,,56422203,689043,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1318,588856,1,1,,56422203,689043,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1319,590194,3,3,,103198532,689043,Unspecified,,,136.5,EC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry,Confirmatory,21377874.0,
1320,590195,6,5,,103198532,689043,Unspecified,6686057.0,,350.0,IC50,Inhibition of mushroom tyrosinase after 25 mins by spectrophotometry,Confirmatory,21377874.0,
1321,592088,3,2,,103198532,689043,Active,,,0.19,IC50,Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs,Confirmatory,21388814.0,
1322,594382,1,11,,103198532,689043,Unspecified,74762622.0,338442.0,,,Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in human HEK293T cells at 10 uM by liquid scintillation counting,Other,21167710.0,
1323,597261,1,5,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity after 20 to 60 mins by spectrophotometry,Other,21507662.0,
1324,597263,3,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean LOX assessed as inhibition of sodium linoleate to 13-hydroperoxylinoleic acid conversion by UV-visible spectrophotometry,Confirmatory,21507662.0,
1325,597264,2,5,,103198532,689043,Unspecified,,,,,Antioxidant activity against AAPH-induced lipid peroxidation assessed as linoleic acid oxidation to diene hydroperoxide at 0.1 mM by UV-visible spectrophotometry,Other,21507662.0,
1326,602123,1,1,,56422203,689043,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1327,602141,1,1,,56422203,689043,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1328,602162,1,1,,56422203,689043,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1329,602163,1,1,,56422203,689043,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1330,602179,1,2,,56422203,689043,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1331,602229,1,1,,56422203,689043,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1332,602233,1,1,,56422203,689043,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1333,602244,1,2,,56422203,689043,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1334,602247,1,2,,56422203,689043,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1335,602248,1,2,,56422203,689043,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1336,602250,1,2,,56422203,689043,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1337,602252,1,1,,56422203,689043,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1338,602252,1,1,,56422203,689043,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1339,602261,1,1,,56422203,689043,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1340,602274,1,2,,56422203,689043,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1341,602276,1,1,,855772,689043,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
1342,602277,1,1,,855772,689043,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
1343,602281,1,1,,56422203,689043,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1344,602281,1,1,,56422203,689043,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1345,602310,1,2,,56422203,689043,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1346,602313,1,1,,56422203,689043,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1347,602329,1,1,,56422203,689043,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1348,602332,1,1,,56422203,689043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1349,602332,1,1,,90340699,689043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1350,602332,1,1,,124883134,689043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1351,602332,1,1,,124883135,689043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1352,602332,1,1,,124883138,689043,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1353,602340,1,2,,56422203,689043,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1354,602342,2,1,,56422203,689043,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1355,602346,1,1,,56422203,689043,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1356,602363,1,1,,56422203,689043,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1357,602393,1,1,,56422203,689043,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1358,602396,1,2,,56422203,689043,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1359,602399,1,2,,56422203,689043,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1360,602405,1,1,,56422203,689043,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1361,602410,1,1,,56422203,689043,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1362,602429,1,1,,56422203,689043,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1363,602438,1,1,,56422203,689043,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1364,602440,1,1,,56422203,689043,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1365,602449,1,2,,56422203,689043,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1366,602481,1,1,,56422203,689043,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1367,609918,3,2,,103198532,689043,Unspecified,,,600.0,IC50,Inhibition of soybean lipoxygenase by UV absorbance based assay,Confirmatory,21757348.0,
1368,617381,1,5,,103198532,689043,Inactive,,,,,Binding affinity to goat brain tubulin by isothermal titration calorimetry,Other,21830815.0,
1369,617745,1,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 1.85 mM after 10 mins relative to control,Other,21840713.0,
1370,617747,1,9,,103198532,689043,Inactive,6686057.0,,,,Inhibition of mushroom tyrosinase using L-DOPA as substrate at 50 uM after 10 mins by UV absorbance method,Other,21840713.0,
1371,623870,1,1,,56422203,689043,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1372,623870,1,1,,56422203,689043,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1373,623877,1,1,,56422203,689043,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1374,623901,1,1,,56422203,689043,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1375,624037,1,3,,56422203,689043,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1376,624038,1,3,,56422203,689043,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1377,624040,1,3,,56422203,689043,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1378,624101,1,2,,85787363,689043,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1379,624125,1,4,,56422203,689043,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1380,624126,1,3,,56422203,689043,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1381,624127,1,2,,56422203,689043,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1382,624136,1,1,,85787363,689043,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
1383,624138,1,1,,85787363,689043,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
1384,624139,1,1,,85787363,689043,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
1385,624141,1,1,,85787363,689043,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
1386,624146,1,1,,90340699,689043,Active,71051501.0,2744.0,1.9953,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1387,624147,1,1,,90340699,689043,Inconclusive,62359610.0,,9.5283,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1388,624148,1,2,,90340699,689043,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1389,624149,1,1,,90340699,689043,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1390,624151,1,1,,85787363,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
1391,624156,1,1,,85787363,689043,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1392,624168,1,1,,56422203,689043,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1393,624169,1,1,,56422203,689043,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1394,624170,1,1,,56422203,689043,Inconclusive,71051501.0,2744.0,17.7828,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1395,624171,1,1,,56422203,689043,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1396,624172,1,1,,56422203,689043,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1397,624173,1,3,,56422203,689043,Inconclusive,62359610.0,,31.6228,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1398,624178,1,1,,56422203,689043,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1399,624202,1,1,,56422203,689043,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1400,624204,1,2,,56422203,689043,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1401,624246,1,1,,56422203,689043,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1402,624256,1,2,,56422203,689043,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1403,624263,1,1,,56422203,689043,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1404,624263,1,1,,56422203,689043,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1405,624263,1,1,,124883134,689043,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1406,624263,1,1,,124883134,689043,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1407,624267,1,2,,56422203,689043,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1408,624267,1,2,,56422203,689043,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1409,624268,1,3,,56422203,689043,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1410,624288,1,1,,56422203,689043,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1411,624296,1,1,,855772,689043,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1412,624296,1,1,,56422203,689043,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1413,624297,1,1,,855772,689043,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1414,624297,1,1,,56422203,689043,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1415,624304,1,2,,56422203,689043,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1416,624330,1,2,,56422203,689043,Inconclusive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1417,624352,1,1,,56422203,689043,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1418,624354,1,1,,56422203,689043,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1419,624377,1,1,,56422203,689043,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1420,624414,1,1,,56422203,689043,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1421,624415,1,2,,56422203,689043,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1422,624416,1,1,,56422203,689043,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1423,624417,1,1,,56422203,689043,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1424,624418,1,1,,56422203,689043,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1425,624455,1,1,,90340699,689043,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1426,624463,1,1,,56422203,689043,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1427,624464,1,1,,56422203,689043,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1428,624465,1,1,,56422203,689043,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1429,624466,1,3,,56422203,689043,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1430,624467,1,1,,56422203,689043,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1431,624483,1,1,,56422203,689043,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1432,630398,3,2,,103198532,689043,Active,,,26.6,IC50,Inhibition of GST-tagged human SHP2 N-terminal SH2 domain deficient mutant PTP activity using pNpp as substrate after 30 mins,Confirmatory,21962577.0,
1433,630399,5,5,,103198532,689043,Unspecified,1718191.0,1845.0,100.0,IC50,Inhibition of GST-tagged human VHR using pNpp as substrate after 30 mins,Confirmatory,21962577.0,
1434,630402,5,5,,103198532,689043,Unspecified,20141721.0,5778.0,100.0,IC50,Inhibition of GST-tagged human HePTP using pNpp as substrate after 30 mins,Confirmatory,21962577.0,
1435,630403,1,9,,103198532,689043,Inactive,84028248.0,5781.0,,,Inhibition of SHP2 in human HepG2 cells assessed as induction of apoptosis measuring PARP cleavage at 50 to 100 uM after 12 hrs by Western blot analysis,Other,21962577.0,
1436,631927,3,2,,103198532,689043,Active,,,0.19,IC50,Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs,Confirmatory,22047800.0,
1437,631930,1,4,,103198532,689043,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,22047800.0,
1438,641085,7,2,,103198532,689043,Active,113596.0,231.0,32.0,IC50,Inhibition of human recombinant N-terminus His6-tagged AKR1B1 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis,Confirmatory,22236472.0,
1439,641086,7,2,,103198532,689043,Unspecified,322510010.0,57016.0,90.0,IC50,Inhibition of human recombinant N-terminus His6-tagged AKR1B10 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis,Confirmatory,22236472.0,
1440,642414,1,9,,103198532,689043,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1441,642415,1,9,,103198532,689043,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1442,647625,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity relative to control,Other,22336384.0,
1443,648156,3,3,,103198532,689043,Active,,,41.0,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity by UV-Vis spectrophotometry,Confirmatory,22385675.0,
1444,648157,1,5,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as trolox equivalents ratio of AAPH radical scavenging activity after 30 mins by ORAC-fluorescein assay,Other,22385675.0,
1445,651550,1,1,,56422203,689043,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1446,651560,1,1,,56422203,689043,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1447,651572,1,2,,56422203,689043,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1448,651582,1,1,,56422203,689043,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1449,651602,1,1,,56422203,689043,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1450,651602,1,1,,56422203,689043,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1451,651602,1,1,,56422203,689043,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1452,651635,1,3,,56422203,689043,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1453,651635,1,3,,90340699,689043,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1454,651636,1,1,,56422203,689043,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1455,651640,1,1,,56422203,689043,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1456,651644,1,1,,56422203,689043,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1457,651647,1,1,,56422203,689043,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1458,651654,1,1,,56422203,689043,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1459,651658,1,1,,56422203,689043,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1460,651660,1,1,,56422203,689043,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors             Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1461,651661,2,1,,56422203,689043,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1462,651687,1,1,,56422203,689043,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1463,651699,1,1,,56422203,689043,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1464,651699,1,1,,56422203,689043,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1465,651702,1,2,,56422203,689043,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1466,651704,2,1,,56422203,689043,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1467,651710,1,1,,56422203,689043,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1468,651711,2,1,,56422203,689043,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1469,651718,1,2,,56422203,689043,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1470,651723,1,1,,56422203,689043,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1471,651724,1,1,,56422203,689043,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1472,651725,1,1,,56422203,689043,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1473,651768,1,2,,56422203,689043,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1474,651800,1,1,,56422203,689043,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1475,651819,1,1,,56422203,689043,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1476,651820,1,1,,855772,689043,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1477,651820,1,1,,56422203,689043,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1478,651821,2,4,,56422203,689043,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1479,651828,1,2,,121361001,689043,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1480,651957,1,1,,56422203,689043,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1481,651958,1,1,,56422203,689043,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1482,651965,1,1,,56422203,689043,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1483,651999,1,1,,56422203,689043,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1484,652010,1,1,,56422203,689043,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1485,652017,1,1,,56422203,689043,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1486,652025,1,1,,56422203,689043,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1487,652039,1,1,,56422203,689043,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1488,652048,1,2,,56422203,689043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1489,652051,1,1,,56422203,689043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1490,652054,1,1,,56422203,689043,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1491,652067,1,4,,56422203,689043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1492,652104,1,1,,56422203,689043,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1493,652105,1,1,,56422203,689043,Inconclusive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1494,652106,1,1,,56422203,689043,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1495,652106,1,1,,90340699,689043,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1496,652115,1,1,,56422203,689043,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1497,652126,1,3,,56422203,689043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1498,652154,1,1,,56422203,689043,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1499,652162,2,1,,56422203,689043,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1500,652163,1,1,,56422203,689043,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1501,652197,1,1,,56422203,689043,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1502,652257,1,1,,56422203,689043,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1503,652654,4,2,,103198532,689043,Unspecified,,,400.0,IC50,Inhibition of COX1 after 5 mins by spectrophotometric analysis,Confirmatory,22386242.0,
1504,652655,4,2,,103198532,689043,Unspecified,,,129.7,IC50,Inhibition of COX2 after 5 mins by spectrophotometric analysis,Confirmatory,22386242.0,
1505,657245,2,2,,103198532,689043,Active,,,4.0,IC50,Inhibition of potato 5-LOX by EIA,Confirmatory,22475926.0,
1506,664544,1,8,,103198532,689043,Unspecified,416877.0,1645.0,,,Inhibition of human recombinant GST-tagged AKR1C1 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry,Other,22506594.0,
1507,664545,1,8,,103198532,689043,Unspecified,20532374.0,1646.0,,,Inhibition of human recombinant AKR1C2 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry,Other,22506594.0,
1508,664546,1,8,,103198532,689043,Unspecified,308153646.0,8644.0,,,Inhibition of human recombinant AKR1C3 expressed in Escherichia coli JM109 cells using S-tetralol as substrate at 100 uM by fluorometry,Other,22506594.0,
1509,664547,1,8,,103198532,689043,Unspecified,308153631.0,1109.0,,,Inhibition of human recombinant GST-tagged AKR1C4 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry,Other,22506594.0,
1510,668898,1,3,,103198532,689043,Unspecified,,,,,Inhibition of nitrite level in LPS-induced mouse RAW264.7 cells at 5 uM by Griess assay relative to LPS treated control,Other,21183258.0,
1511,668899,1,3,,103198532,689043,Unspecified,,,,,Inhibition of nitrite level in LPS-induced mouse RAW264.7 cells at 50 uM by Griess assay relative to LPS treated control,Other,21183258.0,
1512,668900,1,3,,103198532,689043,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells at 5 uM by MTT assay,Other,21183258.0,
1513,668901,1,3,,103198532,689043,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay,Other,21183258.0,
1514,682747,2,2,,103198532,689043,Active,,,37.1,IC50,Inhibition of soybean 15-lipoxygenase using linoleic acid as substrate incubated for 5 mins prior to substrate addition measured after 7 mins by DMAB-MBTH method,Confirmatory,22917856.0,
1515,683122,2,3,,103198532,689043,Active,,,39.4,IC50,Inhibition of soybean 15-lipoxygenase by MBTH-DMAB method,Confirmatory,23047230.0,
1516,683741,1,4,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging activity at 0.1 mM after 10 mins by tetrazolium dye assay,Other,22126405.0,
1517,686940,1,1,,56422203,689043,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1518,686964,1,1,,56422203,689043,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1519,686970,1,2,,56422203,689043,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1520,686971,1,2,,56422203,689043,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1521,686977,2,1,,49699041,689043,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1522,686978,1,1,,56422203,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1523,686978,1,1,,124883134,689043,Inconclusive,79154014.0,55775.0,25.929000000000002,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1524,686978,1,1,,124883135,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1525,686978,1,1,,124883136,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1526,686979,1,1,,56422203,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1527,686979,1,1,,124883134,689043,Inconclusive,79154014.0,55775.0,23.1093,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1528,686979,1,1,,124883135,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1529,686979,1,1,,124883136,689043,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1530,686992,2,1,,56422203,689043,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1531,686996,1,1,,56422203,689043,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1532,687014,1,1,,56422203,689043,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1533,687016,1,1,,56422203,689043,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1534,687035,1,1,,163564162,689043,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1535,687037,1,3,,163564162,689043,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1536,688479,3,1,,103198532,689043,Unspecified,112927.0,351.0,,IC50,Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,Confirmatory,22921742.0,
1537,690970,2,3,,103198532,689043,Active,,,5.7,IC50,Antioxidant activity of the compound assessed as DPPH radical scavenging activity after 60 mins,Confirmatory,22981331.0,
1538,690971,1,2,,103198532,689043,Unspecified,,,,,Inhibition of HFIP pretreated self-mediated amyloid beta (1 to 40) aggregation at 20 uM after 24 hrs by thioflavin-T based fluorimetric assay,Other,22981331.0,
1539,690972,1,2,,103198532,689043,Unspecified,,,,,Inhibition of HFIP pretreated AChE-induced amyloid beta (1 to 40) aggregation at 100 uM after 24 hrs by thioflavin-T based fluorimetric assay,Other,22981331.0,
1540,690974,1,3,,103198532,689043,Active,,,,,Neuroprotective activity in mouse HT22 cells assessed as protection against glutamate-induced cell death at 3 to 30 uM preincubated for 30 mins prior to glutamate challenge measured after 24 hrs by MTT assay,Other,22981331.0,
1541,691434,3,5,,103198532,689043,Unspecified,6686288.0,100157809.0,1000.0,IC50,Inhibition of porcine pancreatic lipase using micellar solution of triolein as substrate preincubated for 5 mins before substrate addition measured after 30 mins,Confirmatory,22995617.0,
1542,691435,1,7,,103198532,689043,Unspecified,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using micellar solution of triolein as substrate at 1 mM preincubated for 5 mins before substrate addition measured after 30 mins,Other,22995617.0,
1543,697852,1,7,,103198532,689043,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1544,697853,1,7,,103198532,689043,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1545,715774,1,2,,103198532,689043,Active,,,,,Induction of free radicals production in carbonate buffer at pH 9 by electron spin resonance analysis,Other,22925447.0,
1546,715775,1,2,,103198532,689043,Active,,,,,Induction of free radicals production in RPMI 1640 medium at pH 7.4 by electron spin resonance analysis,Other,22925447.0,
1547,715791,1,2,,103198532,689043,Inactive,,,,,Induction of apoptosis in human U937 cells assessed as activation of caspase-3 at 1000 uM after 48 hrs by colorimetric assay,Other,22925447.0,
1548,715796,1,2,,103198532,689043,Inactive,,,,,Induction of apoptosis in human U937 cells assessed as reduction of normal cells at 1000 uM after 24 hrs by Annexin V-FITC double staining,Other,22925447.0,
1549,715800,1,2,,103198532,689043,Inactive,,,,,Inhibition of clonogenic activity in human U937 cells assessed as reduction of colony formation in soft agar at 100 to 250 uM after 24 hrs using crystal violet staining,Other,22925447.0,
1550,715802,2,2,,103198532,689043,Unspecified,,,2000.0,CC50,Cytotoxicity against human U937 cells after 48 hrs by trypan blue assay,Confirmatory,22925447.0,
1551,715803,2,2,,103198532,689043,Unspecified,,,316.5,IC50,Antiproliferative activity against human U937 cells assessed as incorporation of [3H]-methyl-thymidine after 12 hrs by scintillation counting,Confirmatory,22925447.0,
1552,716597,1,2,,103198532,689043,Unspecified,,,,,Antiinflammatory activity in LPS-activated mouse RAW264.7 cells assessed as inhibition of LPS induced TNFalpha production treated 30 mins prior to LPS challenge measured after 6 hrs by RT-PCR analysis,Other,22963087.0,
1553,716598,1,2,,103198532,689043,Unspecified,,,,,Cytotoxicity against MDCK cells at 100 uM,Other,22963087.0,
1554,716602,1,2,,103198532,689043,Unspecified,,,,,Antiinflammatory activity in LPS-activated mouse RAW264.7 cells assessed as inhibition of LPS induced IL6 production treated 30 mins prior to LPS challenge measured after 6 hrs by RT-PCR analysis,Other,22963087.0,
1555,716603,1,4,,103198532,689043,Inactive,,,,,"Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in BALB/c mouse assessed as protection from virus-induced death at 1.2 umol/kg/day, intranasally administered bid on days 1 to 4 and day 0 of infection measured after 12 days",Other,22963087.0,
1556,716610,1,4,,103198532,689043,Active,,,,,"Antiviral activity against Influenza A virus (A/California/07/2009(H1N1)) infected in BALB/c mouse assessed as protection from virus-induced death at 12 umol/kg/day, intranasally administered bid on days 1 to 4 and day 0 of infection measured over 14 days",Other,22963087.0,
1557,716613,1,4,,103198532,689043,Unspecified,,,100.0,EC50,Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in MDCK cells assessed as inhibition of virus induced cytopathic effect,Confirmatory,22963087.0,
1558,716614,2,1,,103198532,689043,Unspecified,84028231.0,,100.0,IC50,Inhibition of Influenza A virus A/WSN/1933(H1N1)) neuraminidase in the presence of 2'-(4-methyl-umbelliferyl)-alphaD-N-acetylneuraminic acid substrate after 10 mins by fluorometric assay,Confirmatory,22963087.0,
1559,720504,1,1,,56422203,689043,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1560,720508,1,1,,56422203,689043,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1561,720509,1,1,,56422203,689043,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1562,720511,1,1,,56422203,689043,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1563,720532,1,1,,124883134,689043,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1564,720532,1,1,,124883135,689043,Inactive,420597.0,,14.1254,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1565,720532,1,1,,124883136,689043,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1566,720532,1,1,,124883138,689043,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1567,720533,1,1,,124883134,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1568,720533,1,1,,124883135,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1569,720533,1,1,,124883136,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1570,720533,1,1,,124883138,689043,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1571,720538,1,2,,90340699,689043,Inactive,220983390.0,410.0,8.4921,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1572,720542,1,2,,56422203,689043,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1573,720543,1,1,,56422203,689043,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1574,720551,1,2,,56422203,689043,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1575,720553,1,2,,56422203,689043,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1576,720559,1,2,,90340699,689043,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1577,720572,1,2,,90340699,689043,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1578,720573,1,2,,90340699,689043,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1579,720579,2,1,,56422203,689043,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1580,720579,2,1,,124883134,689043,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1581,720580,1,1,,56422203,689043,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1582,720580,1,1,,124883134,689043,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1583,720582,1,1,,56422203,689043,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1584,720596,1,1,,56422203,689043,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1585,720647,1,2,,56422203,689043,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1586,720648,1,1,,56422203,689043,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1587,720700,1,4,,56422203,689043,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1588,720702,1,1,,56422203,689043,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1589,720704,1,4,,56422203,689043,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1590,720706,1,2,,56422203,689043,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1591,720707,1,2,,56422203,689043,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1592,720708,1,2,,56422203,689043,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1593,720709,1,2,,56422203,689043,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1594,720711,1,2,,56422203,689043,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1595,721517,1,6,,103198532,689043,Inactive,32129514.0,54583.0,,,Displacement of 2OG from catalytic domain of PHD2 (181 to 426) (unknown origin) Zn2 expressed in Escherichia coli at 150 uM,Other,23234607.0,
1596,724462,1,2,,103198532,689043,Active,,,0.002,IC50,Antiproliferative activity against human T47D cells after 5 days by MTT assay,Confirmatory,23228470.0,
1597,725981,1,3,,103198532,689043,Unspecified,,,300.0,IC50,Inhibition of CMG2 (40 to 217) C175A and R40C double mutant (unknown origin) interaction to full length PA E733C mutant expressed in Escherichia coli by FRET assay,Confirmatory,23394144.0,
1598,730190,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Respiratory syncytial virus assessed as reduction of virus-induced cytopathic effect at maximal non-toxic concentration,Other,23333151.0,
1599,733990,1,3,,103198532,689043,Unspecified,,,,,Toxicity against mouse Mel-Ab cells at 100 uM by resazurin dye reduction assay,Other,23305921.0,
1600,735579,2,5,,103198532,689043,Active,269849668.0,4318.0,0.01,IC50,Inhibition of MMP9 in human Hep3B cells using gelatin as substrate,Confirmatory,23375794.0,
1601,735580,1,2,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for human recombinant MMP1 to IC50 for human recombinant MMP9,Other,23375794.0,
1602,735581,1,2,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for human recombinant MMP1 to IC50 for human recombinant MMP2,Other,23375794.0,
1603,735582,2,5,,103198532,689043,Active,269849668.0,4318.0,0.02122,IC50,Inhibition of human recombinant MMP9 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,Confirmatory,23375794.0,
1604,735583,2,5,,103198532,689043,Active,116856.0,4313.0,0.02426,IC50,Inhibition of human recombinant MMP2 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,Confirmatory,23375794.0,
1605,735584,2,5,,103198532,689043,Active,116852.0,4312.0,0.23890999999999998,IC50,Inhibition of human recombinant MMP1 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,Confirmatory,23375794.0,
1606,736486,1,2,,103198532,689043,Active,,,17.9,IC50,Antioxidant activity assessed as inhibition of ABTS radical formation for 15 mins by spectrophotometric analysis,Confirmatory,23357310.0,
1607,736487,1,3,,103198532,689043,Unspecified,,,,IC50,Antioxidant activity assessed as inhibition of DPPH radical formation measured every min for 45 mins by spectrophotometric analysis,Confirmatory,23357310.0,
1608,743126,1,1,,56422203,689043,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1609,743205,1,1,,90340699,689043,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1610,743205,1,1,,90340699,689043,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1611,743206,1,1,,90340699,689043,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1612,743206,1,1,,90340699,689043,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1613,743207,1,1,,90340699,689043,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1614,743207,1,1,,90340699,689043,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1615,743238,1,1,,56422203,689043,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1616,743244,1,1,,90340699,689043,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1617,743247,1,2,,56422203,689043,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1618,743255,1,1,,56422203,689043,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1619,743266,1,2,,56422203,689043,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1620,743269,1,1,,56422203,689043,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1621,743269,1,1,,56422203,689043,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1622,743279,1,2,,56422203,689043,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1623,743397,1,1,,56422203,689043,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1624,743398,1,1,,56422203,689043,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1625,745284,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as xanthine-xanthine oxidase-induced superoxide anion radical scavenging activity at 0.1 mM after 10 mins by spectrophotometry,Other,23567956.0,
1626,750738,1,2,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for Gloeobacter violaceus ligand-gated ion channel E177A mutant to IC50 for wild-type Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes,Other,23682762.0,
1627,750739,1,2,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for Gloeobacter violaceus ligand-gated ion channel R105A mutant to IC50 for wild-type Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes,Other,23682762.0,
1628,750740,1,2,,103198532,689043,Unspecified,,,,,Selectivity ratio of IC50 for Gloeobacter violaceus ligand-gated ion channel R77A mutant to IC50 for wild-type Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes,Other,23682762.0,
1629,750741,1,2,,103198532,689043,Inactive,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of buffer at pH 4 -induced currents at 100 uM after 30 secs by voltage clamp technique,Other,23682762.0,
1630,750742,1,2,,103198532,689043,Inactive,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer-induced currents at 1 mM at pH 5.5 measured after wash-out by voltage clamp technique,Other,23682762.0,
1631,750743,1,1,,103198532,689043,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel E177A mutant at 100 uM,Other,23682762.0,
1632,750744,1,1,,103198532,689043,Inactive,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel R133A mutant at 1 mM,Other,23682762.0,
1633,750745,1,1,,103198532,689043,Unspecified,,,506.0,IC50,Inhibition of Gloeobacter violaceus ligand-gated ion channel E177A mutant,Confirmatory,23682762.0,
1634,750746,1,1,,103198532,689043,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel R105A mutant at 100 uM,Other,23682762.0,
1635,750747,1,1,,103198532,689043,Unspecified,,,420.0,IC50,Inhibition of Gloeobacter violaceus ligand-gated ion channel R105A mutant,Confirmatory,23682762.0,
1636,750748,1,1,,103198532,689043,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel R77A mutant at 100 uM,Other,23682762.0,
1637,750749,1,1,,103198532,689043,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel E181A mutant at 100 uM,Other,23682762.0,
1638,750750,1,1,,103198532,689043,Unspecified,,,945.0,IC50,Inhibition of Gloeobacter violaceus ligand-gated ion channel R77A mutant,Confirmatory,23682762.0,
1639,750751,1,1,,103198532,689043,Active,,,24.1,IC50,Inhibition of Gloeobacter violaceus ligand-gated ion channel E181A mutant,Confirmatory,23682762.0,
1640,750752,1,1,,103198532,689043,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,23682762.0,
1641,750755,1,2,,103198532,689043,Unspecified,,,,,Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents at 1 mM after 30 secs by voltage clamp technique,Other,23682762.0,
1642,750756,3,1,,103198532,689043,Active,,,16.7,IC50,Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique,Confirmatory,23682762.0,
1643,758222,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity after 20 mins by spectrophotometric analysis,Other,23746477.0,
1644,758223,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as superoxide radical scavenging activity measured every 30 seconds for 5 mins by spectrophotometric analysis,Other,23746477.0,
1645,758225,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as ABTS radical scavenging activity after 6 mins by spectrophotometric analysis,Other,23746477.0,
1646,758229,3,2,,103198532,689043,Unspecified,,,,IC50,Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins by spectrophotometric analysis,Confirmatory,23746477.0,
1647,758230,2,3,,103198532,689043,Unspecified,113037.0,43.0,100.0,IC50,Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis,Confirmatory,23746477.0,
1648,758233,1,1,,103198532,689043,Unspecified,,,129.0,IC50,Cytotoxicity against human AGS cells after 96 hrs by MTT assay,Confirmatory,23746477.0,
1649,758236,1,1,,103198532,689043,Active,,,27.16,IC50,Cytotoxicity against human HT-29 cells after 96 hrs by MTT assay,Confirmatory,23746477.0,
1650,758237,1,1,,103198532,689043,Active,,,29.73,IC50,Cytotoxicity against human HCT116 cells after 96 hrs by MTT assay,Confirmatory,23746477.0,
1651,761678,1,5,,103198532,689043,Active,6686057.0,,,,Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 23 uM after 30 mins by spectrophotometric analysis,Other,23796767.0,
1652,761680,1,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Fusarium graminearum ATCC 24373 at 50 ug/ml after 24 hrs by agar well diffusion method relative to control,Other,23796767.0,
1653,761681,1,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Aspergillus flavus IMI 052104 at 50 ug/ml after 24 hrs by agar well diffusion method relative to control,Other,23796767.0,
1654,761682,1,2,,103198532,689043,Unspecified,,,,,Antibacterial activity against Aspergillus niger A3 at 50 ug/ml after 24 hrs by agar well diffusion method relative to control,Other,23796767.0,
1655,761683,1,2,,103198532,689043,Inconclusive,,,,,Antibacterial activity against Candida albicans ATCC 10231 at 50 ug/ml after 24 hrs by agar well diffusion method relative to nystatine,Other,23796767.0,
1656,761689,1,3,,103198532,689043,Active,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity at 3.3 uM measured every 10 mins,Other,23796767.0,
1657,762933,1,1,,103198532,689043,Inactive,,,,,Antimelanogenic activity in mouse B16F10 cells assessed as inhibition of alpha-MSH-induced melanin production at 1 to 2 uM after 72 hrs by spectrophotometry,Other,23876066.0,
1658,763541,1,1,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as inhibition of ABTS free radical generation at 9 uM after 20 mins by UV spectrophotometric analysis relative to control,Other,23777828.0,
1659,763542,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of ABTS free radical generation at 17 uM after 20 mins by UV spectrophotometric analysis relative to control,Other,23777828.0,
1660,768168,1,2,,103198532,689043,Active,,,0.15,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 15 mins by spectrophotometry,Confirmatory,23811091.0,
1661,768171,1,5,,103198532,689043,Unspecified,1351132.0,497756.0,87.45,IC50,Inhibition of rat intestine sucrase using sucrose as substrate incubated for 10 mins prior to substrate addition measured after 40 mins by glucose oxidase colorimetric method,Confirmatory,23811091.0,
1662,768173,1,5,,103198532,689043,Active,81885339.0,367562.0,34.69,IC50,Inhibition of rat intestine maltase using maltose as substrate incubated for 10 mins prior to substrate addition measured after 40 mins by glucose oxidase colorimetric method,Confirmatory,23811091.0,
1663,768175,1,1,,103198532,689043,Unspecified,,,,,Inhibition of yeast type 1 alpha-glucosidase using PNPG as substrate at 10 mg/ml incubated for 10 mins prior to substrate addition measured after 20 mins by spectrophotometry,Other,23811091.0,
1664,768928,1,5,,103198532,689043,Inactive,135807.0,2147.0,,,Inhibition of human thrombin amidolytic activity using D-Phe-Pip-Arg-pNA as substrate at 0.1 to 1000 uM preincubated for 10 mins followed by substrate addition measured every 12 secs for 10 mins by spectrophotometric analysis,Other,24610996.0,
1665,780232,1,2,,103198532,689043,Active,,,15.3,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry,Confirmatory,24080105.0,
1666,780241,1,1,,103198532,689043,Inactive,,,,,Cytotoxicity against human LNCAP cells at 1 uM after 24 hrs by WST-1 assay,Other,24080105.0,
1667,780242,1,1,,103198532,689043,Unspecified,,,100.0,IC50,Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay,Confirmatory,24080105.0,
1668,977599,1,1,,103198532,689043,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1669,977602,1,2,,103198532,689043,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
1670,1053197,1,1,,56422203,689043,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1671,1056513,1,1,,103198532,689043,Inactive,,,,,Antiviral activity against HIV1 infected in human 293T cells expressing VSV-G assessed as inhibition of viral p24 production at 10 uM after 48 hrs by ELISA,Other,24279769.0,
1672,1056514,1,1,,103198532,689043,Inactive,,,,,Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1673,1056515,1,2,,103198532,689043,Inactive,,,,,Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1674,1056516,1,1,,103198532,689043,Inactive,,,,,Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1675,1056517,1,2,,103198532,689043,Inactive,,,,,Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1676,1056518,1,1,,103198532,689043,Inactive,,,,,Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1677,1056519,1,2,,103198532,689043,Inactive,,,,,Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay,Other,24279769.0,
1678,1056520,1,1,,103198532,689043,Unspecified,,,,,Antiinflammatory activity in rat polymorphonuclear leukocytes assessed as inhibition of PAF-induced release of glucuronidase at 10 uM,Other,24279769.0,
1679,1062030,1,1,,103198532,689043,Active,,,20.2,IC50,Inhibition of Streptococcus mutans OMZ65 recombinant sortase A delta-40 mutant using Dabcyl-QALPETGEE-Edans as substrate after 1 hr by fluorescence spectrophotometry,Confirmatory,24360605.0,
1680,1064674,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis,Other,24411196.0,
1681,1064676,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 17 uM after 20 mins by spectrophotometric analysis,Other,24411196.0,
1682,1064677,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity of the compound assessed as inhibition of ABTS radicals at 33 uM after 20 mins by spectrophotometric analysis,Other,24411196.0,
1683,1070388,1,1,,103198532,689043,Inactive,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay,Other,24245939.0,
1684,1070389,1,1,,103198532,689043,Inactive,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis,Other,24245939.0,
1685,1070390,1,1,,103198532,689043,Unspecified,,,,,Cytotoxicity against mouse HT22 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay,Other,24245939.0,
1686,1076845,1,1,,103198532,689043,Inconclusive,,,,,Cytotoxicity against human NCI-H292 cells assessed as reduction in viable cells by MTT assay,Other,24582984.0,
1687,1076846,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against planktonically grown Candida albicans ATCC 10231 by CLSI M27 A3 broth microdilution method,Other,24582984.0,
1688,1076847,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against mature preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay,Other,24582984.0,
1689,1076848,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against early stage preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay,Other,24582984.0,
1690,1076849,1,1,,103198532,689043,Unspecified,,,,,Inhibition of biofilm formation of Candida albicans ATCC 10231 by XTT reduction assay,Other,24582984.0,
1691,1083148,1,1,,103198532,689043,Inactive,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis at 1000 ug/mL measured 24 hr after immersion in compound test solutions,Other,23136941.0,
1692,1083149,1,1,,103198532,689043,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
1693,1083154,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1694,1083155,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1695,1083156,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1696,1083157,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1697,1083158,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1698,1083159,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1699,1083160,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1700,1083161,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1701,1083162,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1702,1083163,1,1,,103198532,689043,Unspecified,,,,,Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control,Other,23145924.0,
1703,1083171,1,1,,103198532,689043,Inactive,,,,,Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days,Other,23145924.0,
1704,1083329,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Unidentified Influenza A virus (H1N2) infected MDCK cells assessed as inhibition of virus-induced cytopathicity,Other,,
1705,1083330,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Unidentified Influenza A virus (H1N2) infected MDCK cells assessed as inhibition of virus-induced cytopathicity,Other,,
1706,1083331,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Feline coronavirus infected feline kidney crandell cells assessed as inhibition of virus-induced cytopathicity,Other,,
1707,1083332,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Respiratory syncytial virus infected human HeLa cells assessed as inhibition of virus-induced cytopathicity,Other,,
1708,1083333,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Human coxsackievirus B4 infected human HeLa cells assessed as inhibition of virus-induced cytopathicity,Other,,
1709,1083334,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Human coxsackievirus B4 infected VERO cells assessed as inhibition of virus-induced cytopathicity,Other,,
1710,1083335,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Mammalian orthoreovirus 1 infected VERO cells assessed as inhibition of virus-induced cytopathicity,Other,,
1711,1083336,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Human parainfluenza virus 3 infected Vero cells assessed as inhibition of virus-induced cytopathicity,Other,,
1712,1083337,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Vesicular stomatitis virus infected HEL cells assessed as inhibition of virus-induced cytopathicity,Other,,
1713,1083338,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Vaccinia virus infected human HEL cells assessed as inhibition of virus-induced cytopathicity,Other,,
1714,1083339,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Human herpesvirus 2 strain G infected human HEL cells assessed as inhibition of virus-induced cytopathicity,Other,,
1715,1083340,1,2,,103198532,689043,Inactive,,,,,Antiviral activity against Human simplex virus 1 KOS infected in human HEL cells assessed as inhibition of virus-induced cytopathicity,Other,,
1716,1083341,1,2,,103198532,689043,Inactive,,,,EC50,Antiviral activity against Sindbis virus infected Hela cells assessed as inhibition of virus-induced cytopathicity,Confirmatory,,
1717,1083342,1,2,,103198532,689043,Inactive,,,,EC50,Antiviral activity against Punta Toro virus infected Hela cells assessed as inhibition of virus-induced cytopathicity,Confirmatory,,
1718,1083343,1,2,,103198532,689043,Inactive,,,,EC50,Antiviral activity against Vesicular stomatitis virus infected Hela cells assessed as inhibition of virus-induced cytopathicity,Confirmatory,,
1719,1083347,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 1 X 10'-4 M,Other,,
1720,1083348,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 1 X 10'-5 M,Other,,
1721,1083349,1,4,,103198532,689043,Unspecified,126398.0,547923.0,,,Inhibition of Glycine max (soybean) lipoxygenase using sodium linoleate as substrate at 1 X 10'-4,Other,,
1722,1083350,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1 X 10'-4 M after 60 min,Other,,
1723,1083351,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1 X 10'-4 M after 20 min,Other,,
1724,1083352,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 5 X 10'-5 M after 60 min,Other,,
1725,1083353,1,3,,103198532,689043,Inconclusive,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 5 X 10'-5 M after 20 min,Other,,
1726,1085185,1,2,,103198532,689043,Active,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as TBRAS level per gram of liver tissue at 10 mg/kg, po administered for 14 days measured after 14 days (Rvb = 0.72 +/-0.12 uM/g)",Other,,
1727,1085186,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as change in body weight at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 190.6 +/-1.78 g)",Other,,
1728,1085187,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as change in body weight at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 205.4 +/-2.68 g)",Other,,
1729,1085188,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in VLDL level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 29.9 +/- 0.83 mg/dl)",Other,,
1730,1085189,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in VLDL level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 14.4 +/- 1.04 mg/dl)",Other,,
1731,1085190,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in LDL level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 68.2 +/- 2.10 mg/dl)",Other,,
1732,1085191,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in LDL level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 52.4 +/- 2.32 mg/dl)",Other,,
1733,1085192,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in HDL level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 36.4 +/- 1.05 mg/dl)",Other,,
1734,1085193,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in HDL level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 40.1 +/- 2.11 mg/dl)",Other,,
1735,1085194,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in total cholesterol level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 131.2 +/- 0.48 mg/dl)",Other,,
1736,1085195,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in total cholesterol level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 98.6 +/- 0.51 mg/dl)",Other,,
1737,1085196,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in triglyceride level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 210.8 +/- 1.25 mg/dl)",Other,,
1738,1085197,1,2,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in triglyceride level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 158.9 +/- 1.23 mg/dl)",Other,,
1739,1085198,1,3,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in blood glucose level at 10 mg/kg, po administered for 14 days measured on day 14 (Rvb = 248.6 +/- 1.20 mg/dl)",Other,,
1740,1085199,1,3,,103198532,689043,Unspecified,,,,,"Antidiabetic activity in alloxan-induced diabetic Rattus norvegicus albino Wistar (rat) model assessed as reduction in blood glucose level at 10 mg/kg, po administered for 14 days measured on day 1 (Rvb = 242.2 +/- 0.71 mg/dl)",Other,,
1741,1085232,1,4,,103198532,689043,Unspecified,126716.0,,,,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated at 300 uM for 10 min before substrate addition and measured after 10 min by spectrophotometry,Other,,
1742,1085233,2,3,,103198532,689043,Unspecified,126716.0,,300.0,IC50,Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 min before substrate addition and measured after 10 min by spectrophotometry,Confirmatory,,
1743,1085314,1,2,,103198532,689043,Active,,,18.25,IC50,Antioxidant activity assessed as DPPH scavenging activity after 30 min by UV-vis spectroscopy,Confirmatory,,
1744,1095400,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production after 30 min by spectrophotometric analysis,Other,,
1745,1095401,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of ABTS radical production after 10 min by spectrophotometric analysis,Other,,
1746,1100608,1,1,,103198532,689043,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 5 umol/disk by paper disk method,Other,84.0,
1747,1100609,1,1,,103198532,689043,Inactive,,,,,Antibacterial activity against Ralstonia solanacearum grown on potato semi-synthetic agar medium at 0.5 umol/disk by paper disk method,Other,84.0,
1748,1116046,1,2,,103198532,689043,Unspecified,,,,,Antimicrobial activity against Streptococcus pyogenes 10535 assessed as growth inhibition after 24 hr by serial dilution method,Other,,
1749,1116047,1,2,,103198532,689043,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus 209 assessed as growth inhibition after 24 hr by serial dilution method,Other,,
1750,1116048,1,2,,103198532,689043,Active,,,,,Inhibition of autoxidation of pure triacylglycerols of sunflower oil at 1 mM by iodometric analysis,Other,,
1751,1116049,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 20 min,Other,,
1752,1116050,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 3.6 mM after 10 min,Other,,
1753,1116051,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 20 min,Other,,
1754,1116052,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 20 min,Other,,
1755,1116053,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 1.8 mM after 10 min,Other,,
1756,1116054,1,3,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.9 mM after 10 min,Other,,
1757,1126662,1,2,,103198532,689043,Active,,,9.48,EC50,Antioxidant activity assessed as DPPH radical scavenging activity by spectrophotometry,Confirmatory,24681984.0,
1758,1159524,1,1,,56422203,689043,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1759,1159524,1,1,,124883134,689043,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1760,1159524,1,1,,124883136,689043,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1761,1159550,3,1,,252402184,689043,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1762,1159580,2,1,,268735857,689043,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1763,1159580,2,1,,273002729,689043,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1764,1159606,1,1,,56422203,689043,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1765,1159607,2,1,,312995585,689043,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1766,1169291,1,2,,103198532,689043,Unspecified,136464.0,7276.0,97.0,EC50,Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay,Confirmatory,25314129.0,
1767,1169299,1,2,,103198532,689043,Inactive,136464.0,7276.0,,,Competitive binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 80 uM by fluorescence assay,Other,25314129.0,
1768,1190809,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 10 uM after 60 mins by spectrophotometry,Other,25597007.0,
1769,1190810,1,2,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 30 uM after 60 mins by spectrophotometry,Other,25597007.0,
1770,1191124,1,2,,103198532,689043,Unspecified,,,,,Inhibition of Pseudomonas aeruginosa recombinant PqsD expressed in Escherichia coli BL21 (lambdaDE3) using ACoA/beta-ketodecanoic acid as substrate at 50 uM after 10 mins,Other,25437621.0,
1771,1191129,1,1,,103198532,689043,Unspecified,,,,,Inhibition of Pseudomonas aeruginosa PA14 PqsH transposon mutant assessed as extracellular level of HHQ at 500 uM after 16 hrs,Other,25437621.0,
1772,1191756,1,2,,103198532,689043,Unspecified,206729922.0,4350.0,,,"Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay",Other,25650313.0,
1773,1193988,1,1,,103198532,689043,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-12 p40 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1774,1193989,1,1,,103198532,689043,Unspecified,,,50.0,IC50,Inhibition of LPS-induced IL-6 production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1775,1193990,1,1,,103198532,689043,Unspecified,,,50.0,IC50,Inhibition of LPS-induced TNF-alpha production in wild-type C57BL/6 mouse BMDC pretreated with compound for 1 hr before LPS treatment measured 16 hrs by ELISA,Confirmatory,25769817.0,
1776,1223489,1,1,,103198532,689043,Unspecified,,,,,"1-Octanol-water distribution coefficient, log D of the compound at pH 7.4 by shake flask method",Other,22096083.0,
1777,1223493,1,1,,103198532,689043,Unspecified,,,,,Apparent permeability from apical to basolateral side in human Caco2 cells at 500 uM at pH 7.4 after 1 hr by HPLC-DAD analysis,Other,22096083.0,
1778,1223494,1,1,,103198532,689043,Unspecified,,,,,Apparent permeability from basolateral to apical side in human Caco2 cells at 500 uM at pH 7.4 after 1 hr by HPLC-DAD analysis,Other,22096083.0,
1779,1223495,1,1,,103198532,689043,Unspecified,,,,,Efflux ratio of apparent permeability from basolateral to apical side over apical to basolateral side in human Caco2 cells at 500 uM after 1 hr by HPLC-DAD analysis,Other,22096083.0,
1780,1224818,1,1,,312344333,689043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
1781,1224819,1,1,,312344333,689043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1782,1224820,1,1,,312344333,689043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1783,1224821,1,1,,312344333,689043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1784,1224822,1,1,,312344333,689043,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
1785,1224823,1,1,,312344333,689043,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1786,1224857,2,1,,312344333,689043,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1787,1224859,2,1,,90340699,689043,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1788,1224864,1,2,,316935243,689043,Inactive,,,,,HCS microscopy assay (F508del-CFTR),Screening,27732613.0,
1789,1224865,1,2,,56422203,689043,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1790,1224905,2,1,,121361001,689043,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1791,1224905,2,1,,121361001,689043,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1792,1227389,1,1,,103198532,689043,Unspecified,,,,,Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells at 100 uM pre-incubated for 24 hrs before H2O2 challenge for 12 hrs by MTT assay,Other,,
1793,1227390,1,1,,103198532,689043,Unspecified,,,,,Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells at 50 uM pre-incubated for 24 hrs before H2O2 challenge for 12 hrs by MTT assay,Other,,
1794,1227391,1,1,,103198532,689043,Unspecified,,,,,Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells at 25 uM pre-incubated for 24 hrs before H2O2 challenge for 12 hrs by MTT assay,Other,,
1795,1227392,1,1,,103198532,689043,Unspecified,,,,,Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells at 12.5 uM pre-incubated for 24 hrs before H2O2 challenge for 12 hrs by MTT assay,Other,,
1796,1227393,1,1,,103198532,689043,Active,,,12.6,EC50,Cytoprotective activity against H2O2-induced cytotoxicity in human EAhy926 cells pre-incubated for 24 hrs before H2O2 challenge for 12 hrs by MTT assay,Confirmatory,,
1797,1244230,1,1,,103198532,689043,Unspecified,126407.0,240.0,10.0,IC50,Inhibition of human 5-LOX expressed in Escherichia coli Bl21 (DE3) assessed as reduction in LTB4 and 5-H(P)ETE) formation pre-incubated for 10 mins before arachidonic acid substrate addition by RP-HPLC method,Confirmatory,26197161.0,
1798,1244231,1,1,,103198532,689043,Unspecified,126407.0,240.0,,,Inhibition of human 5-LOX expressed in Escherichia coli Bl21 (DE3) assessed as remaining enzyme activity by measuring LTB4 and 5-H(P)ETE) formation at 10 uM pre-incubated for 10 mins before arachidonic acid substrate addition by RP-HPLC method,Other,26197161.0,
1799,1244232,1,1,,103198532,689043,Active,126407.0,240.0,8.5,IC50,Inhibition of 5-LOX in human neutrophils assessed as reduction in LTB4 and 5-H(P)ETE) formation pre-incubated for 15 mins before A23187 and arachidonic acid substrate addition by RP-HPLC method,Confirmatory,26197161.0,
1800,1244234,1,1,,103198532,689043,Active,,,9.9,EC50,Cytotoxicity against human U937 cells assessed as reduction in viability incubated for 24 hrs by MTT assay,Confirmatory,26197161.0,
1801,1248048,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 200 ug/ml after 3 hrs by TBA-MDA test,Other,26344590.0,
1802,1248049,1,1,,103198532,689043,Unspecified,,,,,Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation after 3 hrs by TBA-MDA test,Other,26344590.0,
1803,1248399,1,1,,103198532,689043,Unspecified,,,4800.0,IC50,Inhibition of alpha-amylase (unknown origin) relative to control,Confirmatory,26395057.0,
1804,1253007,1,1,,103198532,689043,Unspecified,,,,,"Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as reduction of serum ALT level at 2.5 mg/kg, po (Rvb = 143.7 +/- 12.5 U)",Other,26410075.0,
1805,1253008,1,1,,103198532,689043,Unspecified,,,,,"Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as reduction of serum AST level at 2.5 mg/kg, po (Rvb = 168.5 +/- 14.7 U)",Other,26410075.0,
1806,1253009,1,1,,103198532,689043,Unspecified,,,,,"Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as increase of SOD activity at 2.5 mg/kg, po (Rvb = 31.4 +/- 8.3 U/mg)",Other,26410075.0,
1807,1253010,1,1,,103198532,689043,Unspecified,,,,,"Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as reduction of MDA level at 2.5 mg/kg, po (Rvb = 30.5 +/- 7.8 nM/mg)",Other,26410075.0,
1808,1253011,1,1,,103198532,689043,Unspecified,,,,,"Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as increase of GSH activity at 2.5 mg/kg, po (Rvb = 29.4 +/- 11.4 uM/gram)",Other,26410075.0,
1809,1253012,1,1,,103198532,689043,Active,,,,,Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat by haematoxylin and eosin staining,Other,26410075.0,
1810,1253013,1,1,,103198532,689043,Active,,,,,Protective activity against isoniazid and rifampicin-induced hepatotoxicity in Wistar rat assessed as decrease of CYP2E1 mRNA expression in liver,Other,26410075.0,
1811,1254173,1,1,,103198532,689043,Active,5915866.0,771.0,9.06,Ki,Inhibition of human catalytic domain of carbonic anhydrase 12 preincubated for 15 mins by stopped-flow CO2 hydration assay,Confirmatory,26498394.0,
1812,1254174,1,1,,103198532,689043,Active,30580372.0,71934.0,10.9,Ki,Inhibition of mouse carbonic anhydrase 13 preincubated for 15 mins by stopped-flow CO2 hydration assay,Confirmatory,26498394.0,
1813,1254175,1,1,,103198532,689043,Active,8928036.0,23632.0,8.71,Ki,Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by stopped-flow CO2 hydration assay,Confirmatory,26498394.0,
1814,1256310,1,1,,103198532,689043,Unspecified,,,,,Increase in glucose-stimulated insulin secretion in rat INS-1E cells at 10'-10 M after 60 mins in presence of 16.7 mM glucose,Other,26465380.0,
1815,1256311,1,1,,103198532,689043,Unspecified,,,,,Increase in glucose-stimulated insulin secretion in rat INS-1E cells at 10'-8 M after 60 mins in presence of 16.7 mM glucose,Other,26465380.0,
1816,1256312,1,1,,103198532,689043,Unspecified,,,,,Increase in glucose-stimulated insulin secretion in rat INS-1E cells at 1 uM after 60 mins in presence of 16.7 mM glucose,Other,26465380.0,
1817,1256314,1,1,,103198532,689043,Unspecified,,,,,Increase in glucose-stimulated insulin secretion in rat INS-1E cells at 10'-8 M after 72 hrs in presence of 16.7 mM glucose,Other,26465380.0,
1818,1256318,1,1,,103198532,689043,Inactive,,,,,Effect on glucose-stimulated insulin secretion in rat INS-1E cells at 10'-12 M after 72 hrs in presence of 3.3 mM glucose,Other,26465380.0,
1819,1259310,1,1,,332876117,689043,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1820,1259310,1,1,,332876536,689043,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1821,1259310,1,1,,332876696,689043,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1822,1259310,1,1,,332876812,689043,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1823,1259313,1,1,,56422203,689043,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1824,1259318,1,1,,56422203,689043,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1825,1259325,1,2,,336954284,689043,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
1826,1259354,1,1,,348422171,689043,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1827,1259370,2,2,,124636739,689043,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1828,1259370,2,2,,124636739,689043,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1829,1259370,2,2,,124636739,689043,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1830,1259389,1,1,,124636739,689043,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1831,1259407,1,1,,363898797,689043,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1832,1259408,1,1,,363895587,689043,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
1833,1259409,1,1,,363898797,689043,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1834,1259410,1,1,,363898797,689043,Unspecified,,,,,CCRIS tumor promotion studies,Other,,
1835,1259411,1,1,,363898797,689043,Active,,,,,CCRIS carcinogenicity studies,Other,,
1836,1259415,1,1,,56422203,689043,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1837,1259416,1,2,,85148368,689043,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1838,1259416,1,2,,340086478,689043,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1839,1259421,1,1,,340086478,689043,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1840,1259423,1,2,,354780921,689043,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1841,1259423,1,2,,354783717,689043,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1842,1259423,1,2,,354911760,689043,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
